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ABSTRACT

Molecular Mechanism of Methyl Jasmonate Induced Apoptosis in Human Cancer
Cells
by
Venkat Laxmi Yeruva
Dr. Stephen W. Carper, Examination Committee Chair
Professor of Biochemistry
University of Nevada, Las Vegas
This study investigated the cytotoxic activity o f four plant derived compounds including
perillic acid (PA), Perillyl alcohol (POH), cis-jasmone (CJ) and methyl jasmonate (MJ)
on a variety of human cancer cell lines: Breast (MDA-MB-435, MDA-MB-231, DC4,
DB46, T47D, SKBR3 and ZR75-1), Prostate (PC-3 and DU-145) and Lung (A549, H520
and H2170). It was demonstrated that these compounds induce cell cycle arrest and
apoptosis by themselves or in combination with other agents. Specifically, MJ decreases
membrane fluidity resulting in an activation of tumor necrosis factor receptor 1 (TNFRl)
which signals apoptosis via caspase 8 and 2. Combination studies demonstrated that
POH, MJ and cisplatin decreased viability, induced cell cycle arrest and activated
TN FRl. These results indicate that plant compounds show promise as an alternate
treatment option and the combination of these compounds with chemotherapeutic drugs
may decrease toxicity and improve efficacy over single agent therapy.
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CHAPTER 1

INTRODUCTION
This dissertation has been organized as manuscripts and the following table outlines all
my papers and their current status.

Manuscript
Chapter 3
PA and MJ induced apoptosis
Chapter 4
Jasmonates induced apoptosis in
NSCLC
Chapter 5
PA and POH induce apoptosis

Journal
TIBETS

Status
In press

Experimental Lung
Research

2006 Nov-Dee;
32(10);499-516.

Cancer Letters

In the process of
review

Chapter 6
Jasmonates induce apoptosis

Cancer
Chemotherapy and
Pharmacology
Cancer Research

Submitted

Chapter 7
MJ acts via TNFRl
Chapter 8
Plant compounds sensitize
breast cancer cells to cisplatin

1.1

Breast Cancer
Research

To be submitted
To be submitted

Purpose of the study

Cancer is a group o f diseases characterized by uncontrolled growth. Cancer is
caused by both external factors like radiation, chemicals, tobacco and infectious
organisms and internal factors like mutations and hormones. These factors may act
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together or in sequence to promote cancer initiation. Sometimes ten or more years pass
between external factor exposure and cancer occurrence and detection. Cancer is the
second leading cause of deaths in US. Lung, breast and prostate cancers account for 50%
of cancer deaths in US [1].
The present treatment options for cancer are surgery, chemotherapy, radiation
therapy and hormone therapy. One or a combination of these therapies have been used
for cancer treatment but have been reported to cause severe side effects [1]. An alternate
treatment option, such as plant compounds, can be efficient and advantageous due to
lower toxicity to normal cells. In recent findings, plant compounds like monoterpenes
and jamonates have been shown to inhibit cancer cell growth and possess anticancer
properties [2-9].

The goal of this research is to study the cytotoxic effects o f

monoterpenes and jasmonates on lung, prostate and breast cancer cells and elucidate their
mechanism of apoptosis.

1.2 Significance of the study
Lung cancer is the leading cause of cancer deaths among men and women. An
estimated 213,380 new cases and about 160,390 deaths are expected to occur in 2007 [1].
Lung cancer is classified as small cell (13%) or non small cell (87%) for treatment
purposes. Cigarette smoking is the major risk factor for lung cancer in addition to
exposure to radiation, air pollution and a history of tuberculosis. Treatment options are
determined by the type and stage of cancer and include surgery, radiation therapy and
chemotherapy. Because most of the patients present with an advanced stage o f cancer
treatment options have not been successful in controlling the disease [1].
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Prostate cancer is the second leading cause of cancer deaths and the most
frequently diagnosed cancer among men in US. An estimated 218,890 new cases and
27,050 deaths are expected to occur in 2007. The treatment options of prostate cancer are
chemotherapy, radiation therapy, hormonal therapy or a combination therapy [1].
Breast cancer is the most frequently diagnosed cancer in women. About 40,000
breast cancer deaths are expected and 200,000 new cases of breast cancer are predicted to
occur in 2007.

The major treatment options of breast cancer are radiation therapy,

chemotherapy, hormone therapy, immunotherapy and sometimes two or more methods
are used in combination [1].
To reduce the number of cancer deaths an alternative treatment method is needed
to supplement the current treatment options. Plant compounds could be employed for
chemotherapeutic purposes. By understanding the cellular mechanism of apoptosis, the
pathways could be manipulated for therapeutic purposes. An earlier report demonstrated
that MJ activated multiple signaling pathways in cancer cells [9].

Our study

demonstrated that MJ activated a death receptor apoptotic pathway as well as a
mitochondrial mediated pathway in lung, prostate and breast cancer cells. This study
indicated that MJ induced multiple signaling pathways. Activation of multiple signaling
pathways is a benefit for patients with mutations in apoptotic pathways. For example if
the patient has mutation to any intrinsic apoptotic proteins (caspase-3, or caspase-9)
jasmonates can still work through other pathways and induce apoptosis.
Ionizing radiation (IR) is one of the treatment options for cancer but it is not very
effective and at high doses affects even normal cells. From an earlier report, cancer cells
will be more sensitive to a combination treatment of plant compounds and low dose
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radiation/chemotherapeutic drugs than by drugs themselves [59]. It will be of interest to
study the sensitivity o f cancer cells to combination treatments (POH, MJ and cisplatin).
Hence, complete mechanistic and combination studies are useful for better therapeutic
option.

Combination studies will also produce useful information in the design of

experiments to test the toxicity of these treatments in animal models and for further
clinical studies.
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CHAPTER 2

LITERATURE REVIEW
2.1 Cancer cell lines
Human non-small cell lung cancer (NSCLC) accounts for 50% of lung cancer
related deaths. To represent NSCLC two well known NSCLC cell lines A549 and H520
were studied. A549 is a human lung adenocarcinoma (glandular properties) cell line
whereas H520 is a lung squamous cell carcinoma (no glandular properties) cell line.
A549 has been reported to express wild type p53 (p53^) and H520 (p53 ) expresses a
non-functional p53. Both cell lines possess the death receptor TNFRl [10,11].
Prostate cancer at initial stages is androgen dependent and has therapeutic options
such as testosterone ablation and radical prostectomy. At advanced stages it becomes
androgen independent which limits therapeutic options. To represent the advanced stage
prostate cancer we have studied androgen insensitive cell lines PC-3 and DU-145. Both
adenocarcinoma cell lines, express TNFRl and also high levels of Bela, but do not
express p53 protein [12,13]
Based on National Cancer Institute current estimates, among the women that are
bom today, 12.7 percent will be diagnosed with breast cancer at sometime in their lives.
To represent breast cancer eight different breast cancer cell lines were used. They
include: DC4, DB46, MDA-MB-231, MDA-MB-435, MCF-7, SK-BR-3, T47-D and ZR-
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751. DC4 and DB46 cell lines were genetically engineered by Dr. S.W.Carper (UNLV)
and the difference between them is heat shock protein 27 (hsp27) [14]. DC4 expresses
normal levels of hsp27 while DB46 constitutively expresses high levels hsp27. MDAMB-231, MDA-MB-435 cells are estrogen receptor negative (ER‘) and have mutant p53,
express caspase-2, caspase-3, bax, bak and TNFRl [15, 16]. MDA-MB-231 cells are
invasive whereas MDA-MB-435 cells are invasive and highly metastatic. MCF-7 cells
are poorly invasive, express ER, p53, bax, bak, caspase-2, TNFRl and mutant caspse-3
[17]. SK-BR-3 cells do not express estrogen receptor and p53 [15]. T-47-D cells express
ER, p21, bax, bak, caspase-2, caspase-3, mutant p53 and does not express TNFRl [17].
ZR-751 cells are non-invasive, express ER, p21 and p53 [15]. Non tumorigenic breast
epithelial cell line, MCFIOA and foreskin cell line, CDC-1070-SK were used as normal
controls. All cell lines were purchased from ATCC (Manassas VA).

2.2 Monoterpenes and cancer
Monoterpenes are non-nutritive dietary compounds found in essential oils of fruits
and vegetables. Limonene, a monocyclic monoterpene, administered in the diet at the
mass percentages of 1-5% inhibited the 7, 12-dimethylbenz [o(|anthracene (DMBA) and
N-methyl-N-nitrosourea (MNU)-induced mammary carcinogenesis in rats [18-21].
However, when limonene was removed from the diet the recurrence of tumor was
observed hence limonene seems to act as cytostatic agent [22].
Perillyl alcohol (POH) is a naturally occurring monoterpene synthesized by the
mevalonate pathway. It is a hydroxylated product formed by the condensation of two
isoprene units. It is found in essential oils of mints, cherries, lavenders, lemongrass, sage.
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cranberries, perilla, wild bergamot, gingergrass, and savin, caraway and celery seeds [23,
24]. POH has been shown to be more effective than its parent compound limonene in
decreasing cancer cell growth and has shown chemo-preventive and therapeutic activity
in DMBA-induced mammary cancer [2]. POH inhibited mouse lung, rat colon, rat liver
and pancreatic tumor models that are induced by 4-(methyl-nitrosoamino)-l-(3-pyridyl)1-butanone (NNK), azoxymethane (AOM) or diethyl-nitrosamine (DEN) [3-6, 25, 26].
In vitro studies have showed that POH inhibited the growth o f human breast, colon, lung,
murine glial, and hamster pancreatic ductal adenocarcinoma cells. [27-32].
Perillic acid (PA) has been found to be the major circulating metabolite of POH in
animals and humans. [33-35]. Both POH and PA inhibit protein isoprenylation and
induce cell cycle arrest at GO/Gl phase [36, 37]. In lung cancer cells POH has been
shown to increase the expression of bax, bid and p21'^^, to induce apoptosis and cell
cycle arrest and decrease the cycling D and cdk2 expression without changing p53 levels
[29]. In H322 and H838 cells POH inhibited growth and activated caspase-3 [29]. Gene
expression analysis showed that a large number of genes were up or down regulated in
H322 and H838 cell lines, which suggests that POH mediates its effects through
posttranslational modifications [29].

2.3 Jasmonates and cancer
Jasmonates are plant stress hormones synthesized in response to injury, insect
attack and wounding [38]. Cis-jasmone and methyljasmonate belong to the jasmonte
family of compounds. Jamonates are synthesized in the lipoxygenase pathway in plants
[38] (Figure 5). It has been reported that jasmonates inhibit the growth of leukemia cells
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and lung cancer cells [7, 39]. Jasmonates have been shown to act directly on
mitochondria and release cytochrome c which leads to apoptosis in leukemia cells [8]. In
lung cancer cells, methyl jasmonate induced apoptosis via reactive oxygen species
production, bax/bclx/s, and caspase-3 activation [39].

2.4 Apoptosis and apoptotic pathway
Cell death can be either a consequence of degenerative process (necrosis) or an
active (apoptosis) process. Necrosis is morphologically different from apoptosis and its
physiological consequences are also different from apoptosis. Necrotic cell death leads to
inflammatory reactions, affects neighboring cells and it is difficult to control whereas
apoptosis can be modulated to maintain cell viability [40,41].
Apoptosis is a programmed cell death that occurs to eliminate unwanted cells. It
can occur by two different mechanisms, extrinsic or intrinsic [40, 41]. The extrinsic
apoptotic mechanism involves death receptor ligands such as tumor necrosis factor alpha
(TNF-a), TNF-related apoptosis inducing ligand (TRAIL) and FAS (CD95/APO-1) [46].
In cancer cells TNF-a plays an important role in cellular responses, including
inflammation and apoptosis [42-45]. TNF-a binds to two membrane receptors, tumor
necrosis factor receptor 1 (TNFRl) and tumor necrosis factor receptor 2 (TNFR2) [43].
TNFRl can be activated by both membrane bound and soluble TNF-a where as TNFR2
activation occurs only by soluble TN F-a.[43, 45].

Following TNFRl and TNFR2

activation, FADD (Fas associated death domain) and TRADD (TNF receptor-associated
death domain) recruitment leads to activation of caspase-8 and MAPK (p38 and ERKl/2)
[45]. Several reports have demonstrated that caspase-8 and mitogen activated protein
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kinase (MAPK) either directly activate caspase-3 via bid or activate the intrinsic
apoptotic pathway [45-48].
Several reports have shown that in response to stimuli the MAPK pathway is
activated which determines cell fate [48].

MAPK is part of an extrinsic apoptotic

mechanism. MAPK proteins signal cells to either inhibit or induce apoptosis depending
on the cell type, stimuli and time of activation. MAPKs (p38 and ERKl/2) regulate a
number of downstream molecules, kinases, scaffold proteins and the balance between
these molecules exerts cellular responses including cell proliferation, cell cycle arrest,
migration, differentiation and apoptosis (48, 49).

UV radiation has been shown to

activate p38-MAPK, induce a G2/M block in the cell cycle and decrease Cdc2 activity in
mammalian cultured cells (50).

Cdc2 phosphorylates BAD and induces neuronal

apoptosis (51, 52). A number of studies have reported that ERKl and ERK2 kinase
activation leads to phoshorylation of other transcription factors including c-Myc and
STAT proteins which results in cell death (52-55). Since it has been shown that the cell
cycle plays a role in apoptosis it would be interesting to study the regulation of the
MAPK pathway on the cell cycle and apoptosis.
Caspases are a family of cysteine proteases which are key mediators of apoptosis.
They are synthesized as inactive proenzymes and activated by cleavage at a specific
aspartate residue. To date, there are 14 caspases which are classified into three groups:
apoptotic initiators (caspase-2, 8, 9 and 10), apoptotic executioners (caspase-3, 6 and 7)
and cytokine precursors (caspase -1, 4, 5 13) [56]. Initiator caspases activate bid by
direct cleavage or indirectly, which signals mitochondria.

The intrinsic apoptotic

mechanism involves mitochondrial membrane potential decrease and cytochrome c

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

release into the cytosol.

Cytochrome c forms an apoptosome complex with apaf-1

(apoptotic protease activating factor-1) and procaspase-9, which activates apoptotic
executioner’s caspase-3, caspase-6 and caspase-7 causing cell death [56-58].

2.5 Combination treatment and cancer
Exposing cancer patients to radiation is one of their treatment options.

It is

known that radiation therapy is limited due to severe toxicity at high doses and minimal
efficacy at low doses. The search for compounds that sensitize cells to radiation will
improve the efficacy of the therapy. Many research groups have reported that exposing
cancer cells to radiation induced cell cycle arrest and apoptosis and activation of
apoptotic proteins MAPK, caspases and PAR? in cancer cells [59]. Usually cancer cells
are more sensitive to a combination treatment of radiation and chemotherapeutic drugs.
Pretreatment o f cancer cells with resveratrol or genistein compounds have sensitized the
cells to ionizing radiation [60].

Hence prior treatment of cancer cells with plant

compounds sensitizes cells to ionizing radiation and would provide an alternate treatment
option against cancer.
Combination treatments with low doses of two or three drugs could be an
approach for cancer treatment because of severe toxicity and several side effects with
regular chemotherapy. Several groups have reported that cancer cells are more sensitive
to combination treatment than to any single drug.

In breast cancer cells, Methyl-(3-

dextrin sensitized cells to chemotherapeutic drugs by increasing the uptake of DNA
damaging drugs at low dose and also showed decreased phosphorylation of Akt,
activation of NF-kB and down regulation of Bcli (antiapoptotic protein) protein [61].

10
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Trastuzamab

with

clinically

achievable

concentrations

of

carboplatin,

4-

hydroxycyclophosphamide, docetaxel and vinorelbine showed synergistic (cooperative
effects) interactions in cancer cell death [62]. It has also been showed that grape seed
extract of lOOpg/ml with doxorubicin (25-75nM) has synergistic effects in cancer cell
growth inhibition and additive effects in cell death of MCF-7 cells [63]. Irofulven in
combination with oxaliplatin led to synergistic activity in human colon, breast and
ovarian cancer cells.

Irofulven by itself blocks the cells at S phase whereas in

combination with cisplatin or oxaliplatin blocks cells at the G l/S phase while increasing
the apoptotic population [64]. From all these studies it will be interesting to investigate
the drug interactions with plant compounds in combination to improve the second line
therapies for cancer.

2.6 Hypothesis
Plant compounds can induce apoptosis in human cancer cell lines via cell signaling
pathways.
To test the hypothesis we will:
1.

Examine sensitivity of POH, PA, CJ and MJ on breast (Chapter 7, 8 and
Appendix), prostate (Chapter 6) and lung cancer cells (Chapter 3 ,4 and 5).

2.

Evaluate cell cycle arrest and apoptosis in all three different types of cancer cells
(Chapter 3-8 and appendix)

3.

Investigate cell signaling pathways (Chapter 3-8 and appendix)

4.

Propose a molecular mechanism for MJ induced apoptosis.

11
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Figure 1: Perillic acid

A
H0 >

Figure 2: Perillyl alcohol

Figure 3:
R=COOH; Jasmonic acid
R=H; Cis-jasmone
R=C00CH3; Methyl jasmonate
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units via the mevalonate pathway (Adapted from McGarvey, D. J. and Croteau, R. 1995).
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CHAPTER 3

PLANT COMPOUNDS INDUCED CELL CYCLE ARREST AND APOPTOSIS IN
LUNG CANCER CELLS
3.1 Abstract
Human lung cancer is the most common cause of cancer deaths. It has been reported that
naturally occurring plant compounds and their metabolites possess anticarcinogenic
activities against different cancers. The effect of plant compounds, methyl jasmonate
(MJ) and perillic acid (PA) on the proliferation of human lung squamous cell carcinoma
cell lines (NCI-H520 and NCI-H2170) and human lung adenocarcinoma cell line (A549)
were studied using proliferation, cytotoxicity assays, flow cytometry, enzyme linked
immunosorbent assay and western analyses techniques.

MJ and PA induced dose

dependent decrease in the proliferation of the lung carcinoma cell lines in vitro. Flow
cytometric analyses indicated S phase and G2/M arrest as well as apoptosis in all cell
lines. PA and MJ significantly (p<0.01) elevated the level of the p53 protein in A549 and
NCI-H2170 but not in the NCI-H520, a low p53 expressing cell line. In conclusion the
mechanism of apoptosis induction does not involve p53.

3.2 Introduction
Lung cancer is the most common cause of cancer deaths among men and women
in the US [1].

The etiology of lung cancer involves multiple genetic abnormalities
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leading to malignant transformation of the bronchial epithelial cells, followed by invasion
and metastasis [2]. One of the most common changes in lung cancer is mutation of the
p53 tumor suppressor gene [3]. The frequency of p53 mutation is highest in small cell
and squamous cell carcinoma [3]. Clinical studies suggest that lung cancers with p53
mutations are more resistant to chemotherapy and radiation [4]. An understanding of the
role o f p53 in human lung cancer will lead to a novel target for the treatment of the
disease.
Naturally occurring plant compounds such as the monoterpenes and jasmonates
represent a new class o f anti-cancer agents with chemopreventive and chemotherapeutic
potentials against a variety of cancers [5, 6].

Perillyl alcohol (POH) is a naturally

occurring monoterpene, metabolized to perillic acid (PA) and dihydroperillic acid
(DHPA) in experimental animals [7]. PA has been reported to inhibit the growth of
human cancer cells in vitro [8, 9]. Although the mechanism of anti-tumor action of the
monoterpenes is not yet known, potential drug related activities have been reported [1012]. The jasmonates are a group of plant stress hormones involved in plant intracellular
signaling and defense in response to injury [13, 14]. Methyl jasmonate (MJ), the most
effective compound in the class has been reported to induce cell death in lymphoblastic
leukemia (MOLT-4) and lung cancer cells cultured in vitro without affecting normal
human blood lymphocytes or erythrocytes [15].
p53 is a tumor suppressor protein that induces either cell cycle arrest or apoptosis,
with the latter activity being important for tumor suppression [16, 17]. The p53 protein is
normally short lived and is maintained at low levels in unstressed mammalian cells,
accumulates in the nucleus and is activated as a transcription factor in response to
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genotoxic and non-genotoxic stresses [18, 19].

p53 induces the expression of

downstream proteins, p21 and bax, that are essential for the inhibition of cell cycle
progression and/or the induction of apoptosis [20]. p21 inhibits cyclin dependent kinases
(cdk2/cdk4) and eventually leads to cell cycle arrest at Gq/Gi and Gz/M phases [21].
Direct activation o f bax by p53 permeabilizes the mitochondrial membrane to release
cytochrome c which leads to caspase-3 activation and apoptosis [23].
Earlier report on POH and PA showed proliferation inhibition of human lung
squamous cell carcinoma cell lines [NCI-H520 and NCI-H2170] in a dose and time
dependent manner [8, 9]. In this study the effects of PA and the naturally occurring
compound MJ on human lung squamous cell carcinoma cell lines (NCI-H520 and NCIH2170) and the lung adenocarcinoma cell line (A549) were investigated.

It was

determined that PA and MJ inhibited the growth of lung cancer cells, induced apoptosis
and increased the expression of p53. In conclusion PA and MJ induced apoptosis does
not involve the p53 protein.

3.3

Materials and methods

Chemicals and reagents
Perillic acid was purchased from Aldrich Chemical Company (Milwaukee, WI).
Methyl jasmonate, protease inhibitors, propidium iodide (PI) and ribonuclease (RNase)
were obtained from Sigma Chemical Company (St. Louis, MO).

Cell culture media

(RPMI, and Ham’s F-12K) were obtained from ATCC (Manassas, VA).

Phosphate

buffered saline (PBS, lacking Ca^^ and Mg^^) was obtained from Invitrogen Corporation
(Grand Island, NY).

Fetal bovine serum (FBS), penicillin (1000 units/ml) and
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streptomycin (1000 pg/ml) (P/S) were obtained from Hyclone Laboratories (Logan, UT).
p53 ELISA kit, protein extraction buffer and alamarBlue were purchased from Biosource
Int., Inc. (Camarillo, CA).

Annexin V-FITC kit was obtained from BD Biosciences

Pharmingen (San Jose, CA).

Sodium dodecylsulfate, bisacrylamide, N,N,N,N*- tetra-

methylehtylenediamine (TEMED) and ammonium persulfate were obtained from BioRad Laboratories (Hercules, CA). p53 protein standard, antibody to p53 and enzyme
conjugated HRP secondary antibody were obtained from Santa Cruz Biotechnology, Inc.
(Santa Cruz , CA).

ECL+ western blotting detection system was from Amersham

Biosciences (Piscataway, NJ).
Cells and cell culture
Human squamous cell carcinoma of the lung (NCI-H520, NCI-H2170), and
human lung adenocarcinoma cell line (A549) were obtained from ATCC (Manassas,
VA). The cells were cultured in appropriate medium supplemented with 10% FBS and
1% Penicillin and Streptomycin. Generally, seeded cells were allowed to grow till 80%
confluent, dislodged by trypsinization, counted and the required number of cells was
taken for each experiment. For treatment, PA or MJ was dissolved in DMSG to give
l.OM stock solutions.

Cells were treated by replacing the culture medium with the

treatment medium containing the desired concentrations of each agent and incubated at
37°C in humidified, 5% CO2 atmosphere. Cells in control wells received medium with
DMSO (<0.3% v/v). At termination, effects of the treatment agents were determined as
described below.
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Proliferation and cytotoxicity assays
The cytotoxic effects of PA and MJ on lung cancer cells were studied using the
alamarBlue assay [24]. AlamarBlue is an oxidation-reduction dye that changes color in
growth medium in response to cell growth. In the reduced (fluorescent) state the dye
appears pink while in the oxidized (non-fluorescent) state it retains the blue color. Cells
(5 X 10^) were seeded in 96-well plates and allowed to adhere overnight. The culture
medium was then replaced with 100 pi of treatment or control medium and incubated at
37°C in humidified 5% COz atmosphere for desired time period. At termination, the
treatment medium was aspirated off and replaced with 100 pi of fresh medium and 10 pi
of the alamarBlue dye. The mixture was incubated at 37°C in humidified, 5% COz for 4
hr and the fluorescence measured at 530nm excitation and 590nm emission wavelengths
using GENios fluorescence plate reader (PHENIX Research Products, Hayward, CA).
Cell viability was determined as follows:
Viability (%) = Fluorescence at 590nm of treated group
Fluorescence at 590nm of untreated group

x 100

Colony formation assay
The long-term effects of agents on cancer cells were determined using the colony
formation assay. Cells were exposed to the agents for 6, 9 or 24 hr, washed with PBS
and placed in culture medium. The cells were then cultured for 14 days prior to staining
with crystal violet and the colonies were counted.
DNA content analyses
DNA content analysis was performed to determine the effects of PA and MJ on
cell cycle progression and apoptosis induction. Cells (0.5-1x10®) were plated in 100mm
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plates and exposed to 0, ImM PA and 2mM MJ for 72 hr. At termination cells were
harvested, counted, washed with IX PBS, fixed in 100% ethanol and stored at 4°C. For
DNA analysis the cells were stained with DNA staining solution (lOOpg/ml PI, 0.1% of
Triton X-100, and 1mg/ml RNase A (DNase-free) in PBS lacking Ca^^ and Mg^"^, 1:1:1
by volume) and analyzed using FACSCalibur flow cytometer (Becton Dickinson, San
Jose, CA). Twenty thousand events were acquired and the proportion of hypodiploid
events and cells in

G q/ G i ,

S and G%/M phases were determined using the DNA analysis

software ModfitLT 3.0 (Verity Software, Topsham, Maine).
Annexin V-FITC assav
The transversion of phosphatidylserine (PS) fi-om the inner to the outer leaflet of
the plasma membrane is an initial event in cells undergoing apoptosis and is assessed by
dual PI and annexin V-FITC staining [24]. To confirm the induction of apoptosis, control
and treated cells were stained with annexin V-FITC and incubated in the dark for 15
minutes according to the manufacturer’s instructions (BD Pharmingen, San Jose, CA).
Acquisition to discriminate between apoptotic and necrotic or dead cells was carried out
by staining the cells-conjugate mixture with 10 pL PI (500pg/mL) solution (BD
Pharmingen, San Jose, CA). All color assessments were logarithmically amplified and
10,000 events were acquired on a FACSCalibur flow cytometer (Becton Dickinson, San
Jose, CA) and analyzed using CellQuest software program (Becton Dickinson, San Jose,
CA). Numeric quantitation of these events was accomplished by population gating.
Expression of p53
The expression levels of p53 in lung cancer cells were determined using both the
enzyme-linked immunosorbent assay (NCI-H520 and NCI-H2170) and western blotting
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techniques (NCI-H520, NCI-H2170 and A549). Control or treated cells (0.5-1x10®) were
harvested and cell lysis was carried out using cell extraction buffer (lOmM Tris, pH 7.4,
lOOmM NaCl, ImM EDTA, ImM EGTA, ImM NaF, 20mM Na4P207, 2mM Na3V04,
1% Triton X-100, 10% glycerol, 0.1% SDS, 0.5% deoxycholate) according to the
manufacturer’s instructions (Biosource Intl. Inc., Camarillo, CA). For Ix 10® cells lOOpl
of extraction buffer containing protease inhibitor and PMSF was added and incubated on
ice for 30 min. The cell lysate was centrifuged at 10000 rpm for 10 min at 4°C and the
supernatant was collected, aliquoted and stored at -20°C. Total protein was determined
using the BCA protein assay kit (Pierce, Rockford, IE).
Quantitative determination of p53 protein was carried out by an ELISA method
according to the manufacturer’s instructions (Biosource Intl. Inc., Camarillo, CA).
Aliquots (lOOpl) of standard and cell lysates (1:10 dilution) were transferred into a 96well plate and incubated for 2 hr at room temperature. The wells were washed with wash
buffer and lOOpl o f detection antibody was added and incubated for 1 hr. The mixture
was again washed with the wash buffer and lOOpl of HRP anti-rabbit antibody was added
and incubated for 30 min at room temperature. After washing with the wash buffer,
stabilized chromogen was added and the mixture was incubated for 30 min at room
temperature. Finally, lOOpl of stop solution was added and the absorbance was read at
450 nm.
Western blot analysis was performed to determine the expression levels of p53
protein. Equal amounts o f protein (lysates) were loaded onto SDS polyacrylamide gel
and electrophoresis was carried. The proteins were transferred to PVDF membrane and
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probed with 1:1000 dilutions of primary and secondary antibodies. The membrane was
developed with ECL+ and proteins were detected using the TYPHOON^'^.

3.4

Statistical analysis

Results were expressed as Mean ± SEM of replicate analyses accompanied by the
number of independent experiments. Statistical analyses were performed using t-test and
ANOVA. Differences at p<0.05 or better were considered statistically significant.

3.5 Results
Perillic acid and methvl jasmonate inhibited the proliferation of lung cancer cells
Exposure to PA or MJ inhibited the proliferation of lung cancer cells in dose
dependent manner (Figure 1). The concentration of PA that inhibited cell proliferation by
50% (IC50) at 72 hr was calculated (Figure 1) to be 2.8mM (A549), 3mM (NCI-H520),
and 2.8mM (NCI-H2170). The 72 hr MJ IC50 values for the respective cell lines were
1.8mM (A549), 2.2mM (NCI-H520), and 1.3mM (NCI-H2170). A549 and NCI-H2170
cells were more sensitive than NCI-H520 to MJ than to PA. The long-term effects of PA
or MJ in lung cancer cells were determined by colony formation assay (CFA) (Figure 2).
There was a significant decrease in survival by PA or MJ at 24 hr in A549, NCI-H520
and NCI-H2170 cells. Treatment with PA for 24 hr inhibited proliferation of A549 by
14%, NCI-H520 by 24% and NCI-H2170 by 24%. In A549, NCI-H520 and NCI-H2170,
2mM MJ showed 55%, 30% and 4% survival respectively (Figure 2).
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PA and MJ induced cell cycle arrest and apoptosis in cancer cells
The effects o f PA and MJ on cell cycle distribution and sub-diploid DNA content
of cancer cells were studied to determine the observed inhibition of proliferation was a
result of cell death via apoptosis. PA and MJ induced an S phase block in A549 and
NCI-H520 as well as Gz/M block in NCI-H2170 cells (Table 1). The cell cycle block in
each cell line was accompanied by an increase in the proportion of hypodiploidy except
inNCI-H520 cells (Table 1).
To confirm the observed cell death was a result of apoptosis, the dual annexin VFITC and PI staining technique was used as explained in methods. Cells in lower left
(LL) quadrant were considered as live cells. Apoptotic (Table 2) cells were calculated as
the sum of cells in lower right (LR) and upper right (UR) quadrants. Cells in upper left
(UL) were considered as necrotic cells. Exposure to ImM PA for 12 hr, the fold increases
in apoptotic cells were 2.26 (A549), 1.03 (NCI-520) and 1.01 (NCI-H2170) respectively
(Table 2). Exposure to 2mM MJ produced 9.62 (A549), 1.47 (NCI-H520) and 1.37
(NCI-H2170) fold increases in apoptotic cells compared to the control (1) (Table 2). The
proportion of necrotic cells was low in each case. The observed proliferation inhibition
was a result of cell cycle arrest and apoptosis induction.
Expression of p53 in A549. NCI-H520 and NCI-H2170 cells
Since the tumor suppressor protein p53 is involved in the regulation of cell cycle
progression, the expression levels of the p53 protein following treatment with PA or MJ
were measured. In NCI-H520 cells PA or MJ did not affect the expression levels of p53
(Table 3; Figure 3) compared to the control. In NCI-H2170 cells PA or MJ treatment
resulted in 2.4 fold increase in the level of p53 compared to the control (1) ( Table 3).
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Western blot analyses revealed that PA or MJ increased the levels of p53 in both A549
andNCI-H2170 cells (Figure 3).

3.6 Discussion and conclusion
Proliferation, cytotoxicity, flow cytometric, ELISA and western blot techniques
were used to evaluate the potential effects of PA and MJ on human lung cancer cell lines
in vitro. PA and MJ inhibited the proliferation of human lung cancer cells in a dose
dependent manner (Figure 1). NCI-H2170 and A549 cell lines were more sensitive to MJ
(ICso: 1.3 and 1.8 mM) than NCI-H520 (IC50: 2.2 mM) cell line (Figure 1).

The

sensitivity of the cell lines to PA appeared to be identical with IC50 values between 2.8
and 3 mM (Figure 1). DNA content analyses using flow cytometric method indicated
that exposure o f the cells to PA or MJ resulted in cell cycle arrest and apoptosis (Table
! )•

Since the early events of apoptosis involve the transversion of phosphatidylserine
from the inner to the outer leaflet of the plasma membrane. The effects of PA or MJ
after 12 hr treatment were studied, time where early apoptotic events would have
occurred. It was found that ImM PA produced 126% increase (A549) and very little
increases (NCI-H520 and NCI-H2170) in the sum of apoptotic cells over the control
respectively (Table 2) while MJ produced 863%, 47%, 37% increases in apoptotic
populations respectively in the same cell lines after 12 hr exposure.

These results

confirm that the observed decrease in viability (Figure 1) in the treated cells was a result
of cell cycle arrest accompanied by apoptosis induction (Tables 1 and 2).
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Cells were exposed to the agents for a short period (6, 9, 24 hr) and long-term
proliferation effects were determined.

It was found that exposure to PA for 24 hr

inhibited proliferation of A549, NCI-H520 and NCI-H2170 cells lines by 14%, 24% and
24% respectively (Figure 2).

Similar treatment with MJ inhibited the long-term

proliferation by 45%, 70% and 96% respectively (Figure 2). This study showed that
long-term proliferation inhibition was a result of the late induction of apoptosis in the
cells treated with these agents.
Since the p53 tumor suppressor protein is involved in the regulation of cell cycle
and induction of apoptosis levels of p53 were measured following treatment with PA or
MJ. In NCI-H2170 cells PA or MJ increased p53 expression. Similar treatment did not
affect the level of p53 in NCI-H520 cells (Table 3). Western blot analyses (Figure 3)
confirmed this trend. Exposure of A549 cells also showed a similar trend compared to
NCI-H2170 cells.

These results indicate that cancer cells with wild type p53 (NCI-

112170 and A549) respond to PA and MJ by increasing the expression level of p53
protein whereas those with the mutant p53 (NCI-H520) did not alter expression level
(Table 3; Figure 3). However, since all the cell lines underwent apoptosis (Tables 1 and
2) following exposure to PA or MJ, we propose that the mechanism of apoptosis
induction in lung cancer cells does not involve p53
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3.9 Figure legends
Figure 1: Cytotoxic effects of PA or MJ in lung cancer cells were measured by
mitochondrial dehydrogenase assay as explained in methods. Panel A: A549 cells were
exposed to varying concentrations of PA or MJ for 72 hr. Panel B: NCI-H520 cells were
exposed to different concentrations of PA or MJ for 72 hr. Panel C: NCI-H2170 cells
were exposed to different concentrations of PA or MJ for 72 hr. Cell viability was
calculated as a percentage of untreated control cells (100%). PA showed significant
growth inhibition at 2mM and higher concentrations in A549 and NCI-H520 (p<0.01). In
NCI-H2170 cells significant growth inhibition was observed with PA from ImM -3mM
(p<0.01). In A549 and NCI-H2170 cells MJ showed significant growth inhibition at all
concentrations studied (p<0.01- p<0.001). MJ showed significant growth inhibition of
NCI-H520 cells at 2 mM -3 mM. Values are Mean ± SD (n=6); results are representative
of three different experiments.
Figure 2: PA and MJ caused long-term proliferation inhibition of cells in culture. Human
lung cancer (A549; NCI-H520; NCI-H2170) cells were exposed to ImM PA or 2mM MJ
for 6hr, 9hr and 24hr and the effects determined by colony formation assay as described
in the Methods section. Colonies (>50 cells/colony) were counted and the cell viability
was calculated as percentage of control groups (100%). PA and MJ showed significant
decrease in survival at 24 hr in all three cell lines (p<0.01). Values are Mean ± SD (n=4,
results are representative of two independent experiments.
Figure 3: p53 expression profile in A549, NCI-H520 and NCI-H2170 cells following 72
hr exposure to the agents. Equal amounts (30pg) of protein were loaded, SDS-PAGE
was carried out and the proteins transferred to PVDF membrane. The membrane was
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probed with 1:1000 dilutions of p53 primary and secondary antibodies and developed
with ECL+. The proteins were detected using the TYPHOON™. Increased p53 levels
were observed in A549 and NCI-H2170 cells but not in NCI-H520 (expresses low levels
of p53).
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Table 1: Effects of PA and MJ on cell cycle distribution and hypodiploidy in lung cancer
cells exposed for 72 hr

Cell line
A549

NCI-H520

NCI-H2170

Cell cycle phases
Gz/M

Go/Gi

S

59.4±4.8

10.0± 1.2

30.7±4.9

5.0±1.7

ImM PA

62.1±2.8

37.9±0.0

O.OiO.O

18.1±2.8

2mM M J

68.2±2.5

28.7±0.5

1.9±0.46

28.2±1.4

Control

49.9±2.9

8.6± 1.0

41.4±3.4

O.liO.l

ImM PA

42.3±2.1

46.5±5.7

11.2±3.5

3.4±0.2

2mM MJ

26.7±2.1

62.3±3.6

11.0±3.4

0.7±0.4

Control

51.9±3.5

45.9±5.3

5.4±3.0

3.0±1.0

ImM PA

48.0±3.9

32.7±2.8

19.3±2.8

14.8±1.2

2mM MJ

58.3±1.5

0±0.0

41.7±1.5

10.9±1.4

Treatment
Control

Apoptosis

Cancer cells (1 x 10®) were plated in lOOnun tissue culture plates and treated with PA or
MJ for 72 hr and analyzed on a FACSCalibur flow cytometer as described in the method.
Values are Mean±SEM o f triplicate analyses. p<0.03 was considered to be significant by
one way ANOVA analysis.
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Table 2: PA and MJ induced apoptosis in lung cancer cells.

Treatment
12 hr
Control
ImM PA
2 mM MJ
Treatment
12 hr
Control
ImM PA
2 mM MJ
Treatment
12 hr
Control
ImM PA
2 mM MJ

Live
91.2±0.0
82.8±2.5
34.8±0.75
Live
48.2±3.8
46.0±2.1
25.0±0.1
Live
90.7±0.05
90.4±0.05
86.8±0.0

A549
Apoptotic
6.5±0.0
14.7±3.7
62.5±0.75
NCI-H520
Apoptotic
50.4±4.2
52.3±2.6
74.1±0.5
NCI-H2170
Apoptotic
8.6±0.2
8.7±0.05
11.8±0.05

Necrotic
2.2±0.0
2.5±1.1
2.7±0.0
Necrotic
1.6±0.3
L7±0.4
0.8m 1
Necrotic
0.7±0.1
0.8±0.1
1.4±G.G5

Cancer cells (1 x 10®) treated with PA or MJ for 12 hr and stained with Annexin V-FITC
and PI and analyzed with FACSCalibur flow cytometer as described in the text. Values
are Mean±SEM of duplicate analyses and p<0.005 from one way ANOVA analysis.
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Table 3: Expression of p53 protein in lung cancer cells treated with PA or MJ.

Treatment
Control
ImM PA
2mM MJ

NCI-H520
NCI-H2170
(pg of p53/pg protein)
3.34±0.004
37.69±0.17
3.67±0.006
85.44±0.31
3.32±0.06
87.10±0.35

Quantitative levels of p53 protein were determined by ELISA
technique according to the manufacturer’s instructions. Results
are representative of duplicate analysis. Values are Mean±SEM
and the P<0.001 for NCI-H520 and P<0.04 for NCI-H2170 cells.
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CHAPTER 4

JASMONATES INDUCE APOPTOSIS AND CELL CYCLE ARREST IN NON
SMALL CELL LUNG CANCER LINES
4.1 Abstract
The jasmonates, cis-jasmone (CJ) and methyl jasmonate (MJ), were investigated for their
effects against NSCLC cell lines A549 and H520. CJ or MJ inhibited the proliferation of
both cell lines in a dose dependent manner as well as induced cell cycle arrest in the
G2/M phase. Apoptosis was observed following treatment with CJ or MJ as indicated by
Hoechst staining and confirmed by dual annexin V-FITC/PI and DAPI staining. p38 and
ERKI/2 phosphorylation was observed with increased expression of bax, p21 and
caspase-3 activity.

These observations indicate that jasmonates may have a therapeutic

value in the treatment of lung cancer.

4.2 Introduction
Lung cancer is the leading cause of cancer deaths in both men and women in the
Western world. The estimated total cancer deaths in the U.S. in 2005 due to tobacco use
were 175,000, accounting for 29% of all cancer deaths [1]. The two most common types
of lung carcinomas are small cell and non-small cell carcinomas. The most common
alteration in lung cancer is mutation of the p53 gene, which is associated with cigarette
smoking and asbestos exposure [2]. The p53 tumor suppressor gene is mutated in >80%
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of small cell carcinoma and in about 50% of squamous cell carcinoma of the lung [2].
Wild-type p53 plays a major role in the suppression of tumor development by a
mechanism of cell cycle arrest or apoptosis in cells subjected to genotoxic or
nongenotoxic stresses [3-5].

Cells lacking the wild-type p53 gene are genetically

unstable and are prone to tumor development [6, 7].
The p53 tumor suppressor gene is a direct transcriptional activator for p21 and the
pro-apoptotic protein bax. Bax and Bcb belong to the Bel; family of proteins that are
major determinants o f cell viability. Bax functions by antagonizing the anti-apoptotic
activities of Bclz [11]. The p53 protein is expressed in cancer cells exposed to stress and
induces the expression o f its downstream effector, bax, which permeabilizes the
mitochondrial membrane to release cytochrome c [8]. Cytochrome c is released into the
cytosol and forms the apoptosome complex ’with apaf-1 (apoptotic protease activating
factor-1) and procaspase-9. The apoptosome then activates caspase-3 by cleaving the
downstream procaspase-3, ultimately causing cell death [9, 10].

p53 induces the

expression of p21WAFl protein in functional p53 cells and p21 has also been shown to
be expressed in non-functional p53 cells [12-14]. p21 is a universal inhibitor of cyclindependent kinases (cdk2/cdk4), thus causing cell cycle arrest at Go/Gi or G2/M phase [1214].
Current treatment options for lung cancer include surgery, chemotherapy and
radiation therapy or any combination of these modalities.

Chemotherapy has an

important role in small cell cancer treatment, but is often relegated to a palliative role for
non-small cell cancers, due to limited efficacy, as well as toxicity or side effects. Hence,
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there is a need to develop novel medical therapies for the treatment of lung cancer,
particularly the non-small cell type.
Several naturally occurring plant compounds with anti-tumor activities have been
reported, though their mechanism(s) of action are not fully understood [15-18]. A novel
class of plant compounds with anti-cancer effects is the jasmonates, consisting of over 25
members including cis-jasmone (CJ) and methyl jasmonate (MJ) that are synthesized in
plants in response to attack or injury [19]. The jasmonates have been reported to inhibit
the growth o f lung and prostate cancer cells cultured in vitro [18, 20, 21]. Although the
mechanism o f action of jasmonates is not yet fully understood, it has been reported that in
A549 cells, they might act through the bax/bclx/s and reactive oxygen species production
or through a direct action on the mitochondrial membrane in human T lymphoblastic
leukemia cells [21, 22].
Mitogen activated protein kinases (MAPK) are activated in response to stimuli to
determine cell fate. MAPK proteins signal cells to either inhibit or induce apoptosis
depending on the cell type, stimuli and time of activation. MAPK pathway plays an
important role by regulating a number of downstream molecules, kinases such as ERKl/2
and p38, scaffold proteins and the balance between these molecules exerts cellular
responses including cell proliferation, cell cycle arrest, migration, differentiation and
apoptosis. It has been reported that MJ induced stress activated c-Jun N-terminal kinase
and p38 MAPK in lymphoid cells [23].
We studied the effects of CJ and MJ on non-small cell lung cancer (NSCLC) cell
lines H520 (human lung squamous cell carcinoma) and A549 (human lung
adenocarcinoma). We found that these jasmonates inhibited the proliferation of both cell
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lines in a dose-dependent manner. The jasmonates increased the expression o f Bclz and
p21 proteins, in both cell lines. Jasmonates also induced the expression o f Bax and
increased the caspase-3 activity. We investigated the MAPK signaling mechanism in
both cell lines exposed to MJ. We observed that MJ induced ERKl/2 phosphorylation in
both cell lines. We also determined that p38 is phosphorylated in H520 cells but not in
A549 at the time points studied. We conclude that the jasmonates induced apoptosis by
activating MAPKs, bax and caspase-3 in lung cancer cells.

4.3

Materials and methods

Chemicals and reagents
Cell culture media (RPMI 1640 and Ham’s F-12K) were obtained from ATCC
(Manassas, VA). Fetal bovine serum (FBS), penicillin (1000 units/ml) and streptomycin
(1000 Dg/ml) (P/S) were purchased from Hyclone Laboratories (Logan, UT).

Cis-

jasmone (CJ), methyl jasmonate (MJ), protease inhibitors, propidium iodide (PI) and
ribonuclease A (RNase A) were obtained from Sigma Chemical Company (St. Louis,
MO). Phosphate buffered saline (PBS, lacking Ca^^ and Mg^"^) was purchased from
Invitrogen Corporation (Grand Island, NY). Annexin V-FITC kit was obtained from BD
Biosciences Pharmingen (San Jose, CA). Protein extraction buffer and alamarBlue were
purchased from Biosource International, Inc. (Camarillo, CA). Sodium dodecyl sulfate,
bisacrylamide,

N,N,N,N*-tetramethylethylenediamine

(TEMED)

and

ammonium

persulfate were obtained from Bio-Rad Laboratories (Hercules, CA). Primary antibodies
to p53, bax, bcL and p21, enzyme conjugated horse radish peroxidase (HRP), secondary
antibodies and protein standards were obtained from Santa Cruz Biotechnology, Inc.
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(Santa Cruz, CA).

ECL+ western blotting detection system was purchased from

Amersham Biosciences (Piscataway, NJ). All other reagents and chemicals were o f the
purest grade and were obtained from reputable vendors.
Cells and cell culture
Human adenocarcinoma of the lung (A549) and human squamous cell carcinoma
of the lung (H520) cell lines were obtained from ATCC (Manassas, VA). The cells were
grown in appropriate medium supplemented with 10% FBS and 1% P/S until the plate
was 80% confluent.

The cells were dislodged by trypsinization, counted, and an

appropriate number of cells were seeded for each experiment. Stock solutions (l.OM) of
CJ or MJ were prepared by dissolving each in DMSO. Treatment concentrations were
prepared by diluting the stock solution in culture medium, with occasional stirring, at
37°C for 2 hr prior to use to insure the agents were dissolved. For the treatment, the
culture medium was replaced with treatment medium containing the desired
concentration of each agent and incubated at 37°C in humidified, 5% CO2 atmosphere.
Cells in control plates received medium containing DMSO (0. 3% v/v).
Cvtotoxicity assav
The cytotoxic effects of CJ and MJ on human lung cancer cell lines were
determined using the alamarBlue assay [24]. Reduction of the alamarBlue dye was foimd
to be proportional to the number of viable cells.

Cells (5x10^) were seeded in flat

bottomed 96-well plates for 15-18 hr to undergo attachment. The culture medium was
replaced with lOOpl o f media containing varying concentrations of CJ or MJ and the cells
exposed for 24 hr. At termination, the treatment medium in each well was replaced with
lOOql o f fresh medium and lOql of the alamarBlue dye. thus the assay only measures
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viability in adherent cells. The cells were incubated at 37°C in humidified 5% CO2 for 4
hr. The fluorescence o f the dye was measured at an excitation wavelength of 530nm and
emission wavelength o f 590nm using GENios fluorescence plate reader (PHENIX
Research Products, Hayward, CA). Attached cell viability was calculated as follows:
Viability (%) = (FLT590 - Blk / FLU590 - Blk) xlOO
FLT59o=Fluorescence o f treatment group at 590nm
FLU590- Fluorescence o f untreated group at 590nm
Blk= Blank
Colonv formation assav
The long-term (delayed) cytotoxic effects of CJ or MJ on the lung cancer cells
were determined using the colony formation assay (CFA) as previously described [18].
The cells were exposed to 0 or 2mM CJ or MJ for 24 hr after which the treatment
medium was aspirated off and the cells washed twice with PBS and once with culture
medium. Fresh, complete medium was then added and the cells were allowed to grow in
humidified CO2 atmosphere at 37°C for 14 days. The medium was decanted, and the
cells were washed with PBS and stained with crystal violet (0.5g/100ml in 95% ethanol).
Colonies (>50 cells/colony) were counted and the percentage survival (% viability) was
calculated relative to the control (100%) group.
Apoptotic assavs
DNA content analysis was performed to determine the effects of CJ and MJ on
cell cycling in the cancer cell lines. Cells (1x10^) were seeded in 100mm tissue culture
dishes and treated as described earlier. At termination, the cells were harvested, counted,
washed with PBS and fixed in 90% ethanol. The cells were then stained with PI staining
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solution (100|ig/ml PI, 0.1% Triton X-100, and Img/ml RNase A (DNase-free) in PBS;
1:1:1 by volume).

Twenty thousand events were acquired on a FACSCalibur flow

cytometer (Becton Dickinson, San Jose, CA). The percentage of the cells at different
phases of the cell cycle was obtained using the DNA analysis software ModFit LT 3.0
(Verity Software House, Topsham, ME).
Dual PI and annexin V-FITC staining was performed to confirm apoptosis
induction by CJ or MJ in the cell lines. The transversion of phosphatidyl serine (PS)
from the inner to the outer leaflet of the plasma membrane is an initial event in cells
undergoing apoptosis and has been used to confirm apoptosis induction [25, 26]. Control
or treated cells were harvested, washed, counted and stained with annexin-V FITC
according to the manufacturer’s instructions (BD Pharmingen, San Jose, CA). Apoptotic
and necrotic cells were differentiated by staining with a mixture of PI (500pg/ml) and
annexin V-FITC solution (BD Pharmingen, San Jose, CA). Annexin V-FITC stains the
pre-apoptotic and apoptotic cells while the PI stains the necrotic cells.

Data on the

fluorescence intensities of the cells were acquired with a FACSCalibur flow cytometry
and analyzed using CellQuest analysis software (Becton Dickinson, San Jose, CA).
Numeric quantization o f the data was accomplished by population gating.
To further confirm apoptosis induction, we studied morphological changes that
are characteristic of apoptosis in lung cancer cells exposed to the jasmonates. The cells
were seeded in 8-well slides, exposed to 0 or 2mM CJ or MJ for 24 hr then the medium
was aspirated off. One set of cells was stained with Hoechst dye (2Dg/ml) while another
set was fixed with paraformaldehyde and stained with DAPl (4’, 6-diamidine-2’phenylindole dihydrochloride, 0.2mg/ml).

For the set stained with Hoechst dye, the
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medium was aspirated off and 50001 of the dye was added to the cells, incubated for 15
min and observed under a fluorescence microscope (Nikon Instruments, Inc. Melville,
NY). The number o f cells in the bright field and Hoechst-stained cells were counted and
the percentage o f cells undergoing apoptosis was calculated as:
% Apoptosis = (Number of Hoechst positive cells/Number of cells in bright field) xlOO.
For cells stained with DAPI, morphological changes (blebbing, chromatin
condensation and nuclear fragmentation) indicative of apoptosis were observed and the
images acquired with the fluorescence microscope (Nikon Instruments, Inc. Melville,
NY).
Protein extraction, western blotting and ELISA assavs
The expression profiles of p53, bax and pro-caspase-3 proteins were determined
using western blotting technique, while those of bclz and p21 proteins were determined
using the ELISA technique. Control and treated cells were harvested, washed, pelleted in
microfuge tubes and stored at -80*^C until analyzed. For protein extraction, 10001 of the
extraction buffer (lOmM Tris, pH 7.4, lOOmM NaCl, ImM EDTA, ImM EOT A, ImM
NaF, 20mM Na4Pz07, 2mM Na3V04, 1% Triton X-100, 10% glycerol, 0.1% SDS, 0.5%
deoxycholate) containing proteinase inhibitor (250|xl/5ml) and PMSF (ImM) was added
for every 1x10^ cells, with occasional mixing every 10 min for 30 min. The cell lysate
was clarified at 13,000 rpm at 4°C for 10 min. The supernatant was collected, aliquoted
into tubes and stored at -80°C. The total protein concentration was determined using the
BCA protein assay kit (Pierce, Rockford, IL).
Aliquots (30 Og) of total protein were loaded, separated on SDS-PAGE and
transferred to PVDF membrane. After blocking with 10% nonfat dry milk containing
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0.05% Tween 20, the membrane was incubated with primary antibodies (1:1000) to p53,
bax, bell, p21 (Santa Cruz Biotechnology, CA), caspase-3 (Pharmingen, San Jose, CA )
or D-actin (Sigma-Aldrich, St Louis, MO) for 2 hr at room temperature. The membrane
was washed three times with western IX wash buffer (12.4 mM trizma, 37.4 mM NaCl,
0.5% TritonX-100, pH 7.4) and probed with HRP or with fluorescent (532 nm) secondary
antibodies (1:1000). The signal was detected with ECL+ detection kit and visualized
with a TYPHOON model 9410 (Amersham Biosciences, Piscataway, NJ). For proteins
that had no detectable signals by western blot, we used the more sensitive ELISA
technique to probe for the quantitative expression of bcL (Biosource International, Inc.,
Camarillo, CA) and p21 (Assay Designs, Inc. Ann Arbor, Ml) according to the
manufacturers’ instructions.
Caspase-3 assav
Cells (0.5

X

10®) were plated in p i 00 tissue culture dish, incubated overnight at

37° C and exposed to CJ and MJ for 24hr. The cells were harvested with trypsin EDTA
and washed once with PBS. Caspase-3

activity was measured according to

manufacturer’s (Oncolmmunin, Inc. Gaithersburg, MD) instructions by using FACS
Calibur flow cytometry.
MAPK assav bv ELISA
p38 and ERKl/2 activity was determined by an ELISA assay kit (Super array,
Frederick MD). Cells (1.5 X 10'*) were plated in a 96-well plate and incubated overnight
in humidified 5% CO2 atmosphere at 37°C. The following day, cells were serum starved
for 18-24 hr, exposed to MJ and assayed. Briefly, adherent cells were fixed to the plate,
washed, blocked and incubated with a primary antibody followed by a secondary

48

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

antibody. Then developing solution was added and the samples were incubated for 10
min at room temp before the stop solution was added. Absorbance was measured at 450
nm.

Relative phosphorylation was normalized to cell number according to

manufacturer’s instructions.

4.4 Statistical analysis
The results were presented as Mean ±SEM of replicate analyses accompanied by
the number of independent experiments. Statistical analyses were performed using t-test.
Differences at p<0.05 or less are considered statistically significant.

4.5 Results
CJ and MJ inhibited the proliferation of lung cancer cells
Both CJ and MJ inhibited the proliferation of lung cancer cells in a dosedependent manner (Figure lA and IB).

The concentrations that inhibited cell

proliferation by 50% (IC50) at 24 hr were 2.5mM (A549) and 2.2mM (NCI-H520) for CJ
(Figure lA), and 2.0mM (A549) and 2.5mM (NCI-H520) for MJ (Figure IB)
respectively. The effects o f exposure to CJ or MJ for 24 hr were also evaluated using a
colony formation assay (Figure 2). Compared to the controls, CJ significantly (p<0.01)
inhibited the long-term proliferation of A549 cells by 50% and NCI-H520 by 75%, while
exposure to MJ significantly (p<0.01) inhibited the long-term proliferation of A549 and
NCI-H520 cells by 42% and 70% respectively (Figure 2).
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CJ and MJ induced cell cycle arrest and apoptosis in lung cancer cells
CJ and MJ induced a significant block at the G2/M phase of the cell cycle in both
A549 (Figure 3B) and H520 (Figure 3C) cell lines accompanied by increased sub-diploid
population. A typical result for a treatment group is shown in panel A. To confirm
whether the observed cell death was as a result of apoptosis, we used dual annexin VFITC (AV) and PI (flow cytometry), Hoechst and DAPI staining (fluorescence
microscopy) techniques were used. For flow cytometric analysis, cells treated with CJ or
MJ for 24 hr were stained with AV/PI and gated into the lower left (LL), lower right
(LR), upper right (UR) or upper left (UL) quadrants based on their fluorescence
intensities along the annexin or PI channels.

Cells in the LL (low annexin, low PI)

quadrant represented live cells; cells in UL (low annexin, high PI) quadrant were
necrotic; cells in LR (high annexin, low PI) quadrant were in early apoptosis, while the
cells in UR (high annexin, high PI) quadrant were not included in the analysis since these
cells have a permeable membrane and hence are expected to easily bind annexin V.
Apoptotic cells were calculated as cells in LR quadrant. Following CJ treatment the
proportion o f apoptotic cells was 9% in A549 (Figure 4A) and 24% in H520 (Figure 4B)
cells. Cells treated with MJ had similar results for apoptosis 14% in A549 and 26% in
H520 cells respectively (Figure 4A and 4B).
When cells were treated with CJ or MJ and stained with Hoechst or DAPI, results
obtained by fluorescence microscopy showed that CJ and MJ induced apoptosis in the
cell lines (Figure 5A and 5B). Exposure to CJ resulted in apoptotic population o f 33% in
A549 and 31% in H520 cells (Figure 5A).

Similarly, MJ resulted in 4% and 14%

apoptotic cells in A549 and H520 cell lines (Figure 5A) respectively.

50

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Staining with

DAPI confirmed that CJ and MJ induced chromatin condensation, blebbing and nuclear
fragmentation as well as morphological changes that are characteristic of apoptosis
(Figure 5B) in the cells. The observed inhibition of proliferation was therefore possibly a
result of cell cycle arrest at the G2/M phase, with apoptosis induction as a consequence of
the cell cycle arrest.
Expression o f p53. bax. bel? and p21 proteins in lung cancer cells
The expression o f proteins regulating cell cycle progression (p21) and apoptosis
(Bax, and Bc^) were examined using western blotting and ELISA techniques (Table I
and Figure 6). We exposed cells to lower concentrations (0.5mM) of jasmonates to obtain
maximum number of cells for signaling mechanism. Although p53 was not detected, CJ
or MJ treatments changed the level of bax by 25% (Figures 6A and 6B) in H520 cells. A
decrease in the level of procaspase-3 was observed in CJ- and MJ-treated H520 cells
(Figures 6A and 6B) compared to the control. Caspase-3 activity was increased in H520
cells in the treatment groups, compared to the control, resulting in a shift in the peak in
the treatment groups (Figure 6C 6D and 6E) as determined by flow cytometry (Figure
6C). Increased expression o f BCI2 in A549 and H520 cells was observed (Table 1).
Exposure to 0.5mM CJ caused 32.7% (A549) and 16% (H520) increases respectively in
Bcl2 (Table 1). Similarly cells treated with 0.5mM MJ observed increases were 25% in
A549 and 4% in H520 (Table 1). Exposure to CJ and MJ increased the expression of p21
protein in A549 and H520 cells (Table 1). Exposure to CJ elicited 166.4% (A549) and
73% (NCI-520) increases in p21, while MJ caused 113% (A549) and 30% (NCI-H520)
increases in the cell lines respectively (Table 1).
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MJ increased MAPK activity
MAPK signaling mechanism was studied to determine the phosphorylation levels
of p38 and ERKl/2. Increased ERKI/2 phosphorylation was observed in both A549
(Figure 7A) and H520 (Figure 7B) cell lines exposed to 3mM MJ. MJ increased p38
phosphorylation in H520 (Figure 7D) but not in A549 (Figure 7C) cell line at the time
points investigated.

4.6

Discussion and conclusion

Jasmonates, novel anticancer agents, have been reported to suppress the
proliferation and induce cell death in prostate, melanoma, lung, lymphoma and leukemia
cells [18, 20, 21]. The experiments presented here as well as previous studies
demonstrated that the jasmonates inhibited the proliferation of NSCLC cell lines A549
and H520 (Figure I).

Survival assays showed that jasmonates inhibit the long-term

proliferation and cell cycle analysis demonstrated a Ga/M block in both cell lines.
Apoptotic studies using flow cytometry and fluorescent microscopy detected an increased
amount of apoptotic cells in treatment groups compared to control even though the
methods resulted in different values for apoptosis. These differences in the amount of
apoptosis detected are most likely due to the techniques used.

CJ and MJ induced

apoptosis in similar signaling pathways by inducing the expression of Bax, Bela, p2I,
activation o f caspase-3 and phosphorylation of MAPK in both the cell lines. Both Bax
(pro-apoptotic) (Figure 6) and Bcl2 (anti-apoptotic) (Table 1) levels increased in H520
cells following treatment with MJ or CJ. Since apoptosis occurred in these cells the
signals for apoptosis were higher then the ability of Bcl2 to inhibit this complex process
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or apoptosis was achieved by a mechanism that did not require mitochondrial
involvement.

To the best of our knowledge this is the first report of the signaling

mechanism of CJ as well as its comparison with MJ.

It is also the first report

demonstrating that MJ can induce the expression of p2I in NSCLC cell lines.
Jasmonates may be good potential agents in the treatment of NSCLC. The results
presented in this study indicate that MJ is capable of inducing cell cycle arrest, apoptosis
and induced expression of pro-apoptotic proteins in NSCLC cell lines. These results are
consistent with earlier studies [18,20-23]. At 0.5mM (a sub IC50 concentration) MJ was
able to increase the expression of Bel: but an earlier study using S.OmM MJ reported no
increased expression o f Bela [22]. The difference in these results is most likely due to the
concentration of MJ used. CJ had very similar effects to MJ, which was expected due to
the similarity in their structures. Earlier studies on MAPK using MJ reported the
phosphorylation of these kinases in A549 and leukemia cells, the results obtained here are
consistent with their reports (Figure 7) [22, 23]. However, apoptosis induction in A549
was not regulated by MAPKs [22]. These results indicate the ability of jasmonates to be
effective agents against lung cancer.
The use of NSCLC cell lines provides a useful model system in which to examine
the effects of cytotoxic agents. A549 and H520 are two cell lines that have been used for
such studies. One major difference between these two cell lines is the expression o f p53
which is functional in A549 and non-functional in H520. p53 is a transcription factor for
p2I and the BcL family of proteins [6-8]. The difference in p53 function would lead to
the prediction that H520 cells should be more resistant to agents that induce apoptosis. A
study using UV radiation reported that H520 cells were indeed more resistant than the
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A549 cell line [27]. However, a recent study using ionizing radiation reported A549 cells
were more resistant than H520 [28]. The studies reported here also indicate that the
A549 cell line is more resistant than the H520 cell line. Table 1 clearly indicates that the
level o f Bcl2 in H520 cells is higher than in A549 cells under all conditions investigated.
Therefore, the greater sensitivity of H520 to jasmonates is not dependent on the level of
Bcl2.

Another interesting difference between the A549 and H520 cell lines is the

response of p38 to MJ.

Figure 7 shows that in the H520 cells p38 phosporylation

increases two hours after exposure while in the A549 cells the phosphorylation decreases
for at least eight hours after exposure.

p38 is a MAPK that has a wide variety of

biological effects including the ability to phosphorylate p53 and increase its activity. So
even though A549 cells express a wild-type p53 if it is not phosphorylated it may not be
playing a major role in the apoptotic signaling pathway, perhaps providing resistance to
the A549 cells.
p21 is a universal inhibitor of CDKs/cyclins that induces cell cycle arrest. An
increased level of p21 was observed in treatment groups (Table 1), which correlates with
the cell cycle arrest in both cell lines (Figure 3). Increased p21 levels are higher in A549
than in H520 (Table 1) which may explain the cell cycle arrest at Gq/G i (Figure 3B)
along with Gz/M (Figure 3B). These results indicate that p21 may be a unique target in
NSCLC, which could stop the proliferation of these cancer cells.
Lung cancer was the leading cause of cancer deaths in the US, among both men
and women, in 2005. NSCLC accounts for more than 80% of all lung cancer cases and
has an overall survival at 5 years of less than 15% [29, 30].

Surgical resection is

recommended for NSCLC but since more than half of patients present with advanced
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disease, complete surgical resection is not possible [31]. Therefore, the need to develop
effective chemotherapies for NSCLC is paramount. The results presented here indicate
that the jasmonates may be useful chemotherapeutic agents in the treatment of NSCLC.
Currently, combination chemotherapy is given to NSCLC patients following surgery.
Clearly, future studies will be needed to determine the efficacy of adding jasmonates to
the NSCLC chemotherapy cocktail.
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4.9 Figure legends
Figure I : Cytotoxicity o f CJ and MJ was determined in human lung cancer cells (A549
and NCI-H520) in culture. Panel A: Cells were exposed to varying concentrations of CJ
for 24 hr and the effects on cell viability assessed by mitochondrial dehydrogenase assay
using alamarBlue dye as described in methods section. Panel B: Cells were exposed to
different concentrations of MJ and the cell viability was determined. Cell viability was
calculated as a percentage o f untreated cells (100%). Values were Mean OSD (n=6);
results are representative of three independent experiments. At concentrations 1.5mM
and higher, there was a significant (p<0.001, one-tailed t-test) decrease in the viability of
A549 and H520 cells compared to the control.
Figure 2: CJ and MJ inhibited the long-term proliferation of lung cancer cells. A549 and
H520 cells were exposed to CJ or MJ for 24 hr, the drugs were washed off and the effects
on long-term cell proliferation were determined.

Colonies (>50 cells/colony) were

counted and the percent survival was calculated as percentage of the control cells (100%).
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Values are MeanDSEM; results are representative of two separate experiments of
duplicate analyses. CJ and MJ significantly inhibited the long-term proliferation of A549
( t p<0.01, one-tailed t-test) and H520 (* p<0.001, one-tailed t-test) lung cancer cells.
Figure 3; CJ and MJ induced cell cycle arrest in lung cancer cells. Cells (1.0x10®) were
exposed to 2mM CJ or 2mM MJ for 24 hr and cell cycle distribution was determined with
FACSCalibur flow cytometry as described in the materials and methods. Values are
MeanDSEM of triplicate analyses.

Data are representative of three different

experiments. Statistical analysis was performed by two-tailed t-test and significant (#
p<0.05). A representative flow cytometer printout from A549 cells treated with 2.0 mm
MJ for 24 hrs and analyzed with ModFit 3.0 software is shown in panel A. A G2/M
block was observed in both A549 (Panel B) and H520 (Panel C) with significant increase
in apoptotic population compared to the control (# p<0.05).
Figure 4: Apoptosis induction by CJ and MJ was determined by Annexin-V FITC. Live,
apoptotic and necrotic cells were analyzed using a FACSCalibur flow cytometry as
described in the materials and methods. Apoptotic cells were calculated as the percent of
cells in the lower right quadrant.

The results are representative of two different

experiments of duplicate analyses and values are represented as MeanDSEM. Panel A:
In A549 CJ and MJ increased the proportion of apoptotic cells (f p<0.01, one-tailed ttest). Panel B: Significant increase in apoptotic cells was observed with CJ and MJ
compared to the control in H520 cells ( t p<0.01, one-tailed t-test).
Figure 5: CJ and MJ induced apoptosis in A549 and H520 cell lines. These cell lines
were exposed to 2mM CJ or 2mM MJ for 24 hr and stained with Hoechst or DAPI as
described in the materials and methods. Panel A: The percentage of Hoechst positive
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cells with morphological changes for apoptosis. The results are representative of two
separate experiments done in duplicates and values are represented as MeanDSEM. CJ
and MJ induced significant amount of apoptosis in A549 (# p<0.05, one tailed t-test) and
H520 ( t p<0.01, one tailed t-test) cells. Panel B: DAPI staining showed chromatin
condensation and nuclear fragmentation the hallmarks of apoptosis in treatment groups
both in A549 and H520 cells. Arrow shows chromatin condensation and nuclear
fragmentation.
Figure 6: Panel A: Representative Western blot of p53 (MW 53 kDa), bax (MW 22 kDa)
and procaspse-3 (MW 36 kDa) expression in H520 cells. Bax expression is increased in
treatment groups and Pro-caspase-3 levels are decreased in treatment groups. Panel B:
Densitometry analysis showed an increased bax and decreased levels of procaspase-3
compared to the control in H520. The percentage change in protein levels compared to
the control was calculated as (treatment-control)Zcontrol x 100. Panel C, D and E: Flow
cytometry analysis determined increased caspase-3 activity by CJ (D) or MJ (E) in H520
cells as shown by the shift in histograms.
Figure 7: MAPK activity was determined by cell based assay with 3mM MJ by exposing
to various time points in both cell lines. Values are MeanDSEM and statistical analyses
showed significant difference between control and treatment. Panel A: In A549 cells
increased phophorylation of ERKl/2 was observed with 3mM MJ starting from 30 min
and decreasing after that ( t p<0.01). Panel B: H520 cells treated with 3mM MJ also
showed increased ERKl/2 activity initiating at 30 min and declining after that ( t p<0.01).
Panel C: p38 activity was lower in treatment groups in A549 than in control. Panel D:
H520 cells showed increased p38 activity starting at 2 hr and declining by 8 hr (# p<0.05)
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Table 1; Expression of Bclz and p21 in lung cancer cell lines treated with CJ and MJ.

Treatment
A549 Control
A549 O.SmMCJ
A549 O.SmMMJ

Bclz
pg/1 X 10“*cells
76.1 D0.002
101.0D0.04^
95.200.04"

p21
pg/1 X lO"* cells
15.800.08
42.100.07"
33.700.08"

H520 Control
H520 O.SmMCJ
H520 O.SmMMJ

108.100.01
126.900.02®
112.7D0.01®

1.5D0.0
2.6 00.02®
2.000.005®

Values are presented as MeanDSEM. The p-values for one-tailed t-test: a = p<0.001, b
p<0.01.
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CHAPTER 5

PERILLYL ALCOHOL AND PERILLIC ACID INDUCED CELL CYCLE ARREST
AND APOPTOSIS IN NON SMALL CELL LUNG CANCER CELLS.
5.1 Abstract
Plant products such as perillyl alcohol have been reported to possess anti-tumor activities
against a number o f human cancers though the mechanism of action has not yet been
elucidated. The effects o f Perillyl alcohol (POH) and its metabolite Perillie acid (PA) on
the proliferation o f non-small cell lung cancer (NSCLC, A549 and H520) cells were
investigated. Both POH and PA elicited dose-dependent cytotoxicity, induced cell cycle
arrest and apoptosis with increasing expression of bax, p21 and caspase-3 activity in both
the cell lines.

Combination studies revealed that exposing the cells to an IC50

concentration of POH or PA sensitized the cells to cisplatin and radiation in a dose
dependent manner. These results indicate that POH and PA in combination therapy may
have chemotherapeutic value against NSCLC.

5.2 Introduction
Lung cancer is the leading cause of cancer deaths in the US among both men and
women. Non small cell lung cancer (NSCLC) accounts for more than 80% of all lung
cancer cases and has an overall survival at 5 years of less than 15% [1, 2]. Current
treatment options for lung cancer include surgery, chemotherapy and radiation therapy.
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Surgery is recommended but complete surgical resection is not always possible because
most patients present with advanced disease [3]. Hence, there is a need to develop
effective chemotherapy against NSCLC.
Perillyl alcohol (POH) is a naturally occurring monoterpene found in essential
oils of mints, cherries, lavenders, lemongrass, sage, cranberries, perilla, wild bergamot,
gingergrass, savin, caraway and celery seeds [4-6]. POH is a hydroxylated product of dlimonene formed by the condensation of two isoprene units. POH is 5 to 10 times more
lethal than limonene and has shown chemo preventive and therapeutic activity in DMBAinduced mammary cancer [7]. POH inhibited 4-(methyl-nitrosoamino)-1-(3-pyridyl)-1butanone (NNK) induced mouse lung tumoregenisis, prevented the azoxymethane
(AOM)-induced rat colon tumor models, inhibited diethyl-nitrosamine (DEN)-induced rat
liver tumors and showed anti-tumor activity against pancreatic tumor models [8-13].
POH also inhibited the growth of human breast, colon, lung, murine glial, and hamster
pancreatic ductal adenocarcinoma cells in vitro [14-19].
POH readily metabolizes to perillie acid (PA) and dihydroperillic acid (DHPA) in
animals, whereas in humans, PA is the major circulating metabolite [20-22]. POH and
PA inhibit the protein prenylating enzymes, protein famesyl transferase and
geranylgeranyl transferase. PA and POH also cause cell cycle arrest at the GO/Gl phase
[23, 24]. POH has been reported to regulate gene expression in lung cancer cells. POH
also increased the expression of bax, bid and p21'^^^ , induced apoptosis and cell cycle
arrest as well as decreased cyclin D and cdk2 expression without changing the levels of
p53 [16]. PA has been shown to inhibit the proliferation of lung cancer cells H322 and
H838 with an increase in caspase-3 activity and cleavage of PARP. DNA microarray
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studies showed that a large number of genes changed expression in these two cell lines,
but analysis suggested that POH may mediate its effects via posttranslational
modifications [16]. Pretreatment of prostate as well as head and neck cancer cells with
POH sensitized the cells to radiation [25,26].
Apoptosis is a process regulated by specific genes and occurs through two major
pathways, extrinsic and intrinsic, in mammalian cells [27].

The extrinsic pathway

involves signals transduced through death receptors while the intrinsic pathway involves
proteins o f the Bcb family. Bax is an apoptotis inducing protein of the Bela family and
its homodimerization or heterodimerization with Bela determines whether or not
apoptosis will occur [28]. Direct activation of bax on the outer mitochondrial membrane
renders the membrane permeable and results in release of cytochrome c. Cytochrome c
forms an apoptosome complex with apaf-1 and caspase-9 in the cytosol which activates
procaspase-3 to caspase-3. The protein p21 is a universal inhibitor of cyclin dependent
kinases (CDKs) that are involved in cell cycle progression along with specific cyclins (B
or D o r E) [29-33].
POH and PA have been reported to inhibit the proliferation of lung cancer cells
[14-16]; however, PA’s mechanism of action remains unknown. We studied the effects
of PA and POH on non-small cell lung cancer (NSCLC) cells and demonstrated that POH
and PA inhibited the growth o f lung cancer cells. Cells treated with PA and POH showed
long-term proliferation inhibition and increased sensitivity to cisplatin and radiation.
POH and PA induced cell cycle arrest and apoptosis in lung cancer cells. We observed
increased expression of Bela, bax, p21 and caspase-3 activity in cells treated with POH
and PA. We conclude that POH and PA induced apoptosis via a caspase-3 pathway.
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5.3

Materials and methods

Chemicals and reagents
Cell culture media (RPMI 1640 and Ham’s F-12K) was obtained from ATCC
(Manassas, VA). Fetal bovine serum (FBS), penicillin (1000 units/ml) and streptomycin
(1000 Dg/ml) (P/S) were purehased from Hyclone Laboratories (Logan, UT). Perillie
acid (PA), perillyl alcohol (POH), protease inhibitors, propidium iodide (PI) and
ribonuclease A (RNase A) were obtained from Sigma Chemical Company (St. Louis,
MO).

Phosphate buffered saline (PBS, lacking Ca^^ and Mg^^) was purchased from

Invitrogen Corporation (Grand Island, NY). Annexin V-FITC kit was obtained from BD
Biosciences Pharmingen (San Jose, CA). Protein extraction buffer and alamarBlue were
purchased from Biosource International, Inc. (Camarillo, CA). Sodium dodecyl sulfate,
bisacrylamide,

N,N,N,N*-tetramethylethylenediamine

(TEMED)

and

ammonium

persulfate were obtained from Bio-Rad Laboratories (Hercules, CA). Primary antibodies
to Bela, bax, and p21, enzyme conjugated horse radish peroxidase (HRP), secondary
antibodies, and protein standards were obtained from Santa Cruz Biotechnology, Inc.
(Santa Cruz, CA).

ECL plus western blotting detection system was purchased from

Amersham Biosciences (Piscataway, NJ). All other reagents and chemicals were of the
purest grade and were obtained from reputable vendors.
Cells and cell culture
Human adenocarcinoma (A549) and squamous cell careinoma (H520) of the lung
were obtained from ATCC (Manassas, VA).

The cells were grown in appropriate

medium supplemented with 10% FBS and 1% P/S until the plate was 80% confluent.
The cells were dislodged by trypsinization, counted and the appropriate number of cells

73

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

seeded for each experiment.

Stock solutions (IM ) of PA or POH were prepared by

dissolving each in DMSG and then were filter sterilized.

The indicated treatment

concentrations were prepared by diluting the stock solution in culture medium, with
occasional stirring at 37°C for 2 hr. For the treatment, the culture medium was replaced
with treatment medium containing the desired eoncentration of each agent and incubated
at 37°C in humidified, 5% CO2 atmosphere. Cells in control plates were supplemented
with medium containing DMSG (00.3% v/v).
Cvtotoxicitv assav
The cytotoxic effects of PA or PGH on human lung cancer cell lines were
determined using the alamarBlue assay [34, 35]. Reduction of the alamarBlue dye is
proportional to the number o f viable cells. Cells (5x10^) were seeded in flat bottomed
96-well plates for 15-18 hrs to undergo attachment. The culture medium was replaced
with lOOpl of media containing (0, 0.5, 1.0, 1.5, 2.0, 2.5 and 3.0 mM) concentrations of
PA or (0, 0.5,1.0, 1.5, and 2.0 mM) concentrations PGH and the cells exposed at 37°C in
humidified 5% CG2 for 24 hrs. At termination, the treatment medium in each well was
replaced with lOOpl o f fresh medium and lOpl of the alamarBlue dye. The cells were
incubated at 37°C in humidified 5% CG2 for 4 hrs. Fluorescence was measured at an
excitation wavelength o f 530 nm and emission wavelength of 590 nm using GENios
fluorescence plate reader (Tecan Systems Inc. San Jose, CA).

Cell viability was

calculated as follows:
Viability (%) = (FLT 590 - Blk / FLU 590 - Blk) xlOO
FLT 59o=Fluorescence o f treatment group at 590nm
FLU 59o= Fluorescence o f untreated group at 590nm
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Blk= Blank
Colony formation assav
The long-term (delayed) cytotoxic effects of PA, POH or a combination of these
agents with cisplatin or ionizing radiation on lung cancer cells were determined using the
colony formation assay (CFA) as described previously [15]. The cells were exposed to 0,
1, 2, 3, 4, and 5 mM concentrations of PA or 0, 0.5, 1.0, 1.5 and 2.0 mM concentrations
of POH for 24 hrs. In combination studies, cells were exposed to the 1C50 concentration
of PA (3.6 mM) or POH (1.4 mM) for 24 hrs followed by treatment with cisplatin for 1 hr
or ionizing radiation (1, 3, 5 and 6 Gy), after which the treatment medium was aspirated,
cells washed with PBS, harvested with trypsin, counted, plated into three 60mm dishes
and incubated in humidified 00% atmosphere at 37°C for 14 days. The medium was then
decanted and cells stained with crystal violet (0.5g/100ml in 95% ethanol). Colonies
(>50 cells/eolony) were counted and the percentage survival (%viability) was calculated
relative to the control (100%) group.
Apoptotic assays
DNA content analysis was performed to determine the effects of 2.0 mM PA or
2.0 mM POH on cell cycling in the cancer cell lines. Cells (1x10®) were seeded in 100
mm tissue culture dishes and treated as described earlier. At termination, cells were
harvested, counted, washed with PBS, fixed in 90% ethanol and stored at 4°C. The cells
were then stained with PI staining solution (lOOpg/ml PI, 0.1% Triton X-100, and
1mg/ml RNase A (DNase-free) in PBS; 1:1:1 by volume). Two thousand events were
acquired on a FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA). The
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percentage o f the cells at different phases of the cell cycle was obtained using the DNA
analysis software Modfit LT 3.0 (Verity Software House, Topsham, ME).
To confirm apoptosis induction by PA and POH, a dual PI and annexin V-FITC
assay was performed. The transversion of phosphatidylserine (PS) from the inner to the
outer leaflet o f the plasma membrane is an initial event in cells undergoing apoptosis and
has been used to confirm apoptosis induction [36, 37]. Control or treated cells were
harvested, washed, counted, and stained with annexin-V FITC according to the
manufacturer’s instructions (BD Pharmingen, San Jose, CA). Apoptotic and necrotic
cells were differentiated by staining cells with a mixture of PI (500pg/ml) and annexin VFITC solution (BD Pharmingen, San Jose, CA).

Annexin V-FITC stains the pre-

apoptotic and apoptotic cells while PI stains necrotic cells. Data on the fluorescence
intensities of the cells were acquired with a FACSCalibur flow cytometer and analyzed
using CellQuest analysis software (Becton Dickinson, San Jose, CA).

Numeric

quantification of the data was accomplished by population gating.
To detect the morphological changes characteristic of apoptosis, cells were seeded
in 8-well slides and exposed to 0 or 2mM PA or POH for 24 hrs. At termination the
medium was aspirated, the cells fixed with paraformaldedyde and stained with DAPI (4’,
6-diamidine-2’-phenylindole dihydrochloride, 0.2mg/ml). For Hoeehst 33342 (20g/m l
Hoechst) staining the medium was aspirated and 50001 of stain was added to the cells
and incubated for 15 min.

Morphological changes (cell blebbing, chromatin

condensation and nuclear fragmentation) indicative of apoptosis were observed and the
images acquired with fluorescence microscopy (Nikon Instruments Inc. Melville, NY).
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The number o f cells in the bright field and Hoechst-stained cells were counted and the
percentage of cells undergoing apoptosis was calculated as:
% apoptosis = (Number of Hoechst positive eells / Number of cells in bright field) xlOO.
Protein extraction, western blotting and ELISA assays
The expression profiles of BcL, and p21 proteins were determined using ELISA
while western blotting techniques were used to measure the levels of bax and procaspase3. Control and treated cells (0.5 mM PA or POH exposure for 24 hrs) were harvested,
washed, pelleted in microfiige tubes and stored at -80^C. For protein extraction, IGODl of
the extraction buffer (lOmM Tris, pH 7.4, lOOmM NaCl, ImM EDTA, ImM EOTA,
ImM NaF, 20mM Na4P20?, 2mM Na3VÜ4, 1% Triton X-100, 10% glycerol, 0.1% SDS,
0.5% deoxycholate) containing protease inhibitor (250pl/5ml) and PMSF (ImM ) was
added for every 1x10® cells, with occasional mixing every 10 min for 30 min. The cell
lysate was clarified at 13,000 rpm at 4°C for lOmin. The supernatant was collected,
aliquoted into tubes and stored at -80°C. Total protein concentration was determined
using a BCA protein assay kit (Pierce, Rockford, IL).
Equal amounts (30 Og) of total protein were loaded, separated on SDS-PAGE and
transferred to a PVDF membrane. After blocking with 10% nonfat dry milk containing
0.05% Tween 20, the membrane was incubated with primary antibodies (1:1000) to bax,
and procaspase-3 (Pharmingen, San Jose, CA) or Dactin (Sigma Aldrich, St Louis, MO)
for 2 hrs at room temperature. The membrane was washed three times with western wash
buffer (12.4 mM trizma, 37.4 mM NaCl, 0.5% TritonX-100, pH 7.4) and probed with
HRP or fluorescent (532nm) secondary antibodies (1:1000). The membranes probed with
HRP signal were detected with ECL plus detection kit and visualized with a Typhoon
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9410 (Amersham Biosciences, Piscataway, NJ) phosphoimager.

The more sensitive

ELISA technique for the quantitative determinations of Bclz (Biosouree International,
Inc., Camarillo, CA) and p21 (Assay Designs Inc. Ann Arbor, MI) were used according
to the manufacturers’ instructions.

5.4

Statistical analyses

The results were represented as Mean ± SEM of duplicate analyses accompanied by a
number of independent experiments.

Statistical analysis was performed using t-test

(Graphpad Software INC., CA, USA and Excel). Differences at p<0.05 or better were
considered statistically significant.

5.5 Results
POH and PA induce cell death in luns cancer cells
POH inhibited the proliferation of A549 and H520 lung cancer cells in a dosedependent manner while PA did not (Figure 1). The concentration of POH at which 50%
of cell proliferation was inhibited following a 24 hrs exposure was 1.7mM in H520 cells
(Figure IB).

The coneentrations of POH at 1.0 mM and above were all statistically

significant from the control values in both the A549 (p = 0.01) and H520 (p = 0.004) cell
lines. The long-term proliferation inhibition of A549 cells evaluated by a survival assay
revealed that both POH and PA resulted in decreased survival in a dose dependent
manner with POH being more lethal than PA (Figure 2A).

The IC50 values (50%

survival) were 1.4 mM and 3.6 mM for POH and PA respectively (Figure 2A).

In

combination studies, cells were first treated with the IC50 PA or IC50 POH
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concentrations followed by cisplatin or radiation. Cells treated with IC50 concentrations
of POH or PA were more sensitive to cisplatin or radiation treatments compared to
cisplatin or radiation alone (Figure 2B and 2C). Cisplatin (IxlO'"^ M) alone did not have
an effect on cell survival, however, if the A549 cells were first treated with the IC50
dose o f PA or POH, survival decreased to 30 or 40% respectively (Figure 2B). Similarly,
a five Gy dose of radiation resulted in 60% survival but if the cells were first treated with
the IC50 dose of PA or POH, survival fell to 20 or 40% respectively (Figure 2C).
POH and PA induced cell cycle arrest and apoptosis in lung cancer cells
PA induced S-phase arrest while POH induced Gq/G i arrest in A549 cells (Table 1).
POH and PA induced Gz/M arrest in H520 cells after 24hrs exposure (Table 1).
Apoptosis induced by POH or PA was determined by flow cytometrie analysis using a
biotin-conjugated Annexin-V (AV)/PI and Hoechst stain. Cells were treated with 2.0
mM POH or 2.0 mM PA for 24 hrs, stained with AV/PI and gated into lower left (LL,
low annexin and low PI), upper left (UL, low annexin, high PI), lower right (LR, high
annexin and low PI) and upper right (UR, high annexin and high PI) quadrants. The cells
in LL were considered live and the cells in UL were necrotic. The cells in LR and UR
were considered to be in early and late apoptosis respectively. Apoptotic cells were
calculated as the sum o f the LR and UR quadrants. The percentage of apoptotic cells in
both A549 and H520 were 12% (control) while PA treatment increased apoptosis to 27%
in A549 (Figure 3A) and to 18% in H520 cells (Figure 3B). POH treatment resulted in
37% apoptotic cells in A549 (Figure 3A) and 48% apoptotic cells in H520 (Figure 3B).
PA and POH treatments resulted in a statistically significant (p < 0.01) increase in
apoptosis in both cell lines. Neither treatment produced necrosis in either cell line.
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POH and PA treated cells were stained with Hoechst 33342 as described in the materials
and methods section. Morphological changes of apoptosis observed with fluorescence
microscopy revealed that POH and PA induced nuclear condensation, blebbing and
nuclear fragmentation as shown in Figure 5. Exposure to 2.0 mM PA resulted in 10%
apoptosis in A549 and 31.5% in H520 cells while treatment with 2.0 mM POH resulted
in 24% apoptosis in A549 and 60% in H520 cells (Table 2).
Bax, bel?. p21 and caspase-3 proteins were up-regulated in POH or PA treatments in lune
cancer cells
ELISA, western blotting and flow cytometric techniques were used to determine the level
o f proteins that were involved in cell cycle arrest and apoptosis (Table 3 and Figure 4).
Cells were exposed to a lower concentration (0.5mM) of agents to obtain the maximum
number o f cells for analysis. In both cell lines PA or POH increased the expression of
Bela, and p21 (Table 3). Exposure to PA induced 18% (A549) and 17% (H520) increases
in Bela expression while POH increased Bela expression by 50% in A549 and 5% in
H520 cells (Table 3). The protein p21, a universal inhibitor of cyclin dependent kinases
involved in cell cycle arrest was inereased by PA or POH treatments in both cell lines.
PA induced 61% (A549) and 100% (H520) increases in p21 expression while POH
increased p21 expression by 50% in H520 cells (Table 3).

Expression of bax and

procaspase-3 in H520 cells shows both agents were capable of inducing bax expression
and both decreased expression levels of procaspse-3 (Figure 4A). Flow cytometric
analysis o f caspase-3 showed a shift towards the right in POH or PA treated cells
indicating increased caspase-3 activity (Figure 4B, 4C and 4D). The results confirm that
treatment with POH or PA results in cell cycle arrest by increasing expression of p2I and
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induced apoptosis in a mitochondrial mediated pathway by increasing the expression of
bax and caspase-3 activity.

5.6

Discussion and conclusion

Monoterpenes have been reported to possess chemotherapeutic and chemo preventive
activities against cancer cells. In vitro studies reported that POH inhibited the growth of
pancreatic, breast and lung cancer cells [14-19]. To determine the chemotherapeutic
effects of POH and PA, proliferation and apoptotic assays were used. This study showed
that POH caused growth inhibition in a dose dependent manner in NSCLC cells. PA and
POH showed long-term proliferation inhibition in A549 cells in vitro. Pretreatment with
either PA or POH in A549 cells resulted in a greater sensitivity to cisplatin and radiation.
Both PA and POH induced cell cycle arrest and apoptosis as well as increased the
expression of Bcb, bax, p21 and activation of caspase-3.
POH is currently being tested in clinical trials, though its mechanism of action has
not been firmly established.

POH and PA may be potential agents for lung cancer

treatment. The results presented here indicate that both agents are capable of inhibiting
cell growth, inducing cell cycle arrest and apoptosis as well as increasing the expression
of pro- and anti-apoptotic proteins in NSCLC cells.

The results are consistent with

earlier reports [14-19]. Earlier studies with POH on NSCLC cells (H322 and H838)
showed the highest percent of eell death after 5 days and the appearance of apoptotic
cells within 24-48 hrs [16].

Increased caspase-3 activity as well as up and down

regulation of cell cycle genes were also observed, which suggested that POH effects are
via post translational modifications [16]. An earlier report showed increased expression
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of cod inhibitor p21 and cycling E in colon cancer cells, while our study on lung cancer
cells also showed increased expression of p21 (Table 3).

The results indicate that

observed cell cycle arrest is most likely due to increased expression of p21 (Table 3) and
also suggests PA or POH as promising chemotherapeutic agents against NSCLC.
Studies on NSCLC indicate that plant compounds may be useful in adjuvant therapy. A
study using POH and PA on head and neck cancer cells (HTB-43 and SCC-25) showed
increased sensitivity to low dose radiation (lo r 2Gy) treatment [25]. In this study, IC50
concentrations of POH or PA sensitized A549 eells to cisplatin or radiation in a dose
dependent manner.
target.

Both cisplatin and ionizing radiation have DNA as their critical

While the specific mechanism whereby the increased cell killing occurs is

unknown, it is interesting to speculate that the monoterpenes may be able to act at
multiple sites not only activating apoptosis signaling pathways but perhaps also being
able to inhibit DNA repair. Monoterpenes could be effective agents in chemo-radiation
therapy o f NSCLC but further studies will be needed to optimize these agents in
combination therapy.
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5.9 Figure legends

Figure 1: Cytotoxicity o f PA and POH was determined in human lung cancer cells (A549
and NCI-H520) in culture. Panel A; Cells were exposed to various concentrations of PA
for 24 hrs. The effects on cell viability were assessed by mitochondrial dehydrogenase
assay using alamarBlue dye as described in the methods section. Panel B: Cells were
exposed to various concentrations of POH and the cell viability was determined. Cell
viability was calculated as a percentage of untreated cells (100%). Values were
Mean±SD (n=6); results are representative of three independent experiments.

At

concentrations of 0.75 mM and higher, POH significantly (p<0.001, one-tailed t-test)
decreased the viability o f A549 and H520 cells compared to the control. Treatment with
PA at 2.5 and 3.0 mM resulted in significant (p<0.05) decreases in cell viability.
Figure 2; Long term proliferation of PA and POH alone or in combination with cisplatin
or ionizing radiation in A549 cells. Panel A: A549cells treated with POH or PA for
24hrs. Panel B; A549 cells were treated with cisplatin for 24 hrs (open circles) or with
the IC50 dose o f either PA (filled downward triangle) or POH (filled upward triangle) for
24 hrs followed by cisplatin. Panel C: A549 cells were treated with ionizing radiation
(filled circles) or with the IC50 dose of either PA (filled downward triangle) or POH
(filled upward triangle) for 24 hrs followed by ionizing radiation.

Values are

Mean+SEM; results are representative of two separate experiments of triplicate analyses.
PA and POH and combination of PA or POH with cisplatin or radiation significantly
inhibited the long-term proliferation of A549 cells (fp<0.01, one-tailed t-test).
Figure 3; Apoptosis induction by PA and POH was determined by Annexin-V FITC.
Live, apoptotic and necrotic cells were analyzed using a FACSCalibur flow cytometry as

88

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

described in the materials and methods. The results are representative of two different
experiments o f duplicate analyses and values are represented as MeanlSEM. Panel A: In
A549 PA (* p<0.05) and POH (tp<0.01) increased the proportion of apoptotic cells.
Panel B: Significant increase in apoptotic cells was observed with PA (* p<0.05) and
POH (tp<0.01) compared to the control in H520 cells.
Figure 4: Panel A: Representative Western blot of bax and procaspse-3 expression in
H520 cells. Bax expression is increased in the treatment groups while procaspase-3 levels
are decreased in the treatment groups. Panels B, C and D: Flow cytometry analysis
determined increased caspase-3 activity by PA (Panel C) or POH (Panel D) in H520 cells
as shown by the shift in histograms eompared to the eontrol (Panel B).
Figure 5: Representative photographs of A549 and H520 cells treated with 2mM PA and
2mM POH for 24 hrs. Cells were stained using Hoechst and the fluoreseence microscopy
images were acquired as described in the methods. Panels A and B are images of the
same field o f A549 cells. Panel A is the bright field image and Panel B is the image taken
with a UV emission filter. Panels C and D are images of the same field of H520 cells.
Panel C is the bright field image and Panel D is the image taken with UV emission filter.
Panels E and F are images of the same field of A549 cells treated with 2mM PA. Panel E
is the bright field image and Panel F is the image taken with a UV emission filter. Panels
G and H are images o f the same field of H520 cells treated with 2mM PA. Panel G is the
bright field image and Panel H is the image taken with a UV emission filter. Panels I and
J are images o f the same field of A549 cells treated with 2mM POH. Panel I is the bright
field image and Panel J is the image taken with a UV emission filter. Panels K and L are
the same field images of H520 cells treated with 2mM POH. Panel K is the bright field
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image and Panel L is the image taken with a UV emission filter.
Figure 6: DNA profiles following treatment with PA and POH. A540 cells (panels A, B
and C) and H520 (panels D, E and F) cells were treated with vehicle (panels A and B) or
1 mM PA (panels B and E) or 1 mM POH (panels C and F) for 24hrs, harvested, fixed in
70% ethanol and stored at 4°C until analyzed.
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Table 1: PA and MJ induced apoptosos in lung cancer cells

Treatment

GO/Gl

S

G2/M

Apoptosis

A549 Control

54.2 ±2.0

32.9 ±2.1

12.2 ± 0.6

0.2 ±0.1

A549 ImM PA

54.3 ± 2.5

*45.4 ±2.3

0.3 ±0.1

2.9 ± 0.6

A549 ImM

*67.8 ± 1.0

24.7 ± 1.21

7.6 ± 0.2

4.4 ± 1.3

H520 Control

47.5 ± 0.9

35.5 ±2.4

17.3 ±1.3

0.0 ± 0.0

H520 ImM PA

50.6 ± 1.7

26.4 ± 1.3

*23.0 ±2.4

0.0 ± 0.0

H520 ImM

48.8 ±0.9

*19.6 ± 1.0

*31.5 ±2.0

0.4 ± 0.3

POH

POH

The values are represented as Mean±SEM of two individual experiments (♦
p< 0.05, one tailed t-test).
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Table 2: POH and PA induced apoptosis as determined by Fluorescent Microscopy

% apoptosis
24 Hr Treatment

A549

H520

0

1.2 + 0.17

2.6 ± 0.84

2mM PA

^10.2 ±2.0

*31.5 ±4.8

2mM POH

*24.3 ± 1.9

* 60.7 ± 10.8

Values are M eanlSEM of two separate experiments. POH
or PA induced significant increase in apoptotic population
both in A549 and in H520 cells compared to the control (f
p<0.01, and # p<0.001).
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Table 3: POH and PA increased the expression of Bclz and p21

Cell line

Treatment

Pg Bcb/lXlO* cells

p g p 2 1/1X10*
cells

A549

H520

Control

76.1 ±0.01

31.8 ±0.06

0.5mM PA

90.2 ± 0.02*

50.4 ± 0.09^

0.5mM POH

114.7 ±0.09^

64.1 ±0.05^

Control

108.1 ±0.01

1.5 ±0.01

0.5mM PA

127.7 ±0.0*

1.6 ±0.05

0.5mM POH

114.1 ±0.04*

2.3 ± 0.03^

Values are Mean+SEM of two separate experiments, (f p<0.01 and * p<0.05).
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CHAPTER 6

METHYL JASMONATE AND CIS-JASMONE INDUCED CELL CYCLE ARREST
AND APOPTOSIS IN PROSTATE CANCER CELLS
6.1 Abstract
Jasmonates are stress hormones synthesized by plants in response to injury and insect
attack.

Methyl jasmonate (MJ) has been reported to inhibit cell growth in several

established cancer cell lines.

Advanced prostate cancer cells typically are hormone

independent, resistant to apoptosis and do not respond to chemotherapeutic agents. The
ability of MJ and cis-jasmone (CJ) to inhibit hormone independent prostate cancer cell
lines (PC-3 and DU-145) was evaluated using both an alamarBlue assay and clonogenic
survival. Flow cytometery and fluorescent microscopy were used to measure cell cycle
distribution and apoptosis. Both CJ and MJ were capable of inhibiting the growth and
inducing cell death in these cell lines. Cell cycle distribution demonstrated that CJ or MJ
induced an S-phase arrest in PC-3 and a GO/Gl block in DU-145 cell lines. Both CJ and
MJ induced apoptosis and mechanistic studies revealed that MJ activated TNFRI and
caspase-3 in prostate cancer cells. The results presented in this study indicated that the
phytochemicals CJ and MJ could be useful in the management of advanced prostate
cancer.
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6.2 Introduction
The risk of an American male developing prostate cancer over his lifetime is one
in six making it the most frequently diagnosed cancer in men [2]. It is the second leading
cause of cancer-related deaths among men in the US. Prostate cancer is asymptomatic at
the beginning with metastatic prostate cancer usually being androgen dependent. The
primary therapy for metastatic prostate cancer is testosterone ablation and radical
prostatectomy [3, 6]. However, in advanced stages prostate cancer becomes androgen
insensitive, which severely limits therapeutic options. Hence there is a need to develop
alternative treatment options for advanced androgen independent prostate cancer. Many
different phytochemicals (both nutritive and non nutritive) have shown potential in the
prevention/treatment of cancer including prostate cancer.
PC-3 and DU-145 are two well-studied androgen independent prostate cancer cell
lines. These cells lines do not express p53 but do express high levels of Bcli which are
thought to lead to the protection of cells [1, 13, 15,21]. However, these two cell lines are
capable of undergoing apoptosis with mitochondrial damage activating the intrinsic
pathway and overcoming the effect of the pro-survival protein Bcli [5, 17]. These cell
lines have been used to study the effects of various phytochemicals and have proven to be
a good model system for advanced prostate cancer.
Plants express a wide variety of compounds that have been reported to have
protective/therapeutic effects against cancer cell lines. Jasmonates are stress hormones
synthesized in plants in response to injury and insect attack [8]. Cis-jasmone and methyl
jasmonate belong to the jasmonate family of compounds and have been shown to inhibit
the growth o f lung and leukemia cells in vitro and induce apoptosis [9, 19,20 ]. Though
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the mechanism of action o f jasmonates is not fully known they have been reported to act
directly on mitochondria in T lympoblastic leukemia cells [19].
The effects of CJ and MJ on prostate cancer cell lines (PC-3 and DU-145) were
studied and found that jasmonates inhibited the proliferation of both cell lines in a dose
and kinetic-dependent manner. Survival assays demonstrated that jasmonates inhibited
the long-term proliferation of prostate cancer cells. They also induced a GO/Gl arrest in
DU-145 and S-phase arrest in PC-3 cells. Investigation on TNFRI demonstrated that MJ
increased the expression o f TNFRI which signals cells to apoptosis. Studies on caspase3 activity in PC-3 cell line demonstrated that jasmonates activated procaspase-3.

In

conclusion, jasmonates induced apoptosis involves activation of caspase-3 and TNFRI in
prostate cancer cells.

6.3

Materials and methods

Chemicals and reagents
Ham’s F-12K and RPMI 1640 media was obtained from ATCC (Manassas, VA).
Fetal bovine serum (FBS) and penicillin (1000 units/ml) and streptomycin (1000 pg/ml)
(P/S) were purchased from Hyclone Laboratories (Logan, UT). Cis asmone (CJ), Methyl
jasmonate (MJ), proteinase inhibitors, propidium iodide (PI) and ribonuclease A (RNase
A) were obtained from Sigma Chemical Company (St. Louis, MO). Phosphate buffered
saline (PBS, lacking Ca^^ and Mg^"^) was purchased from Invitrogen Corporation (Grand
Island, NY). AlamarBlue was purchased from Biosource International, Inc. (Camarillo,
CA).

Sodium dodecyl sulfate, bisacrylamide, N,N,N,N*-tetramethylethylenediamine

(TEMED) and ammonium persulfate were obtained from Bio-Rad Laboratories
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(Hercules, CA). Caspase-3 fluorimetric kit was obtained from Calbiochem (San Diego,
CA).
Cells and cell culture
Hormone independent human prostate adenocarcinoma cell lines (DU-145, PC3)
were obtained from ATCC (Manassas, VA).

The cells were grown in appropriate

medium supplemented with 10% FBS and 1% P/S until the plate was 80% confluent.
The cells were dislodged by trypsinization, counted and the appropriate number of cells
seeded for each experiment.

Stock solutions (IM ) of CJ or MJ were prepared by

dissolving each in DMSO. The indicated treatment concentrations were prepared by
diluting the stock solution in culture medium, with occasional stirring at 37°C for 2 hr.
For the treatment, the culture medium was replaced with treatment medium containing
the desired concentration of each agent and incubated at 37°C in humidified, 5% CO2
atmosphere. Cells in control plates received the medium with DMSO (<0.3% v/v). At
termination, the effects o f the agents were determined as described below.
Cvtotoxicitv assav
The cytotoxic effects of CJ or MJ on human prostate cancer cell lines were
determined using the alamarBlue assay [12].

Reduction of the alamarBlue dye is

proportional to the number o f viable cells. Cells (5x10^) were seeded in flat bottomed
96-well plates for 15-18 hr to undergo attachment. The culture medium was replaced
with 100 pi of media containing varying concentrations of CJ or MJ and the cells exposed
at 37°C in humidified 5% CO2 for 24 hr. At termination, the treatment medium in each
well was replaced with lOOpl of fresh medium and lOpl of the alamarBlue dye. The cells
were incubated at 37°C in humidified 5% CO2 for 4 hr. Fluorescence was measured at an
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excitation wavelength of 530 nm and emission wavelength of 590 nm using GENios
fluorescence plate reader (PHENIX Research Products, Hayward, CA). Cell viability
was calculated as follows:
Viability (%) = (FLT590 - Blk / FLU590 - Blk) x l 00
FLT59o=Fluorescence of treatment group at 590nm
FLU590- Fluorescence o f untreated group at 590nm
Blk= Blank
Colonv formation assav
The long-term (delayed) cytotoxic effects of CJ or MJ on the prostate cancer cells
were determined using the colony formation assay (CFA). The cells were exposed to
different concentrations of CJ or MJ for 24 hr. The treatment medium was aspirated off
and the cells were washed with PBS, harvested with trypsin EDTA. Cells were counted,
plated into 60mm dishes and incubated at 37°C in humidified CO2 atmosphere for 10-14
days. The medium was decanted and the cells were stained with crystal violet
(0.5g/100ml in 95% ethanol).

Colonies (>50 cells/colony) were counted and the

percentage survival (%viability) was calculated relative to the control ( 100%) group.
Proliferation assav
The effect of CJ and MJ on the proliferation of human prostate cancer cell lines
was assessed by proliferation assay. Cells (O.lx 10^) were plated in 60 mm dishes and
incubated overnight at 37°C in humidified 5% CO2. Following adhesion plates were
divided into three groups: control and treatments. Control cells received 0.1% DMSO
and treatment groups received 2mM MJ or CJ for 9 days. Cells were harvested with
trypsin-EDTA and the number of cells was counted using a Coulter counter. The
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procedure was followed everyday for up to 5 days and then every other day (7 and 9).
Proliferation inhibition o f PC3 and DU-145 was assessed by comparing the number of
cells in treatment groups with control group.
Flow cvtometrv
DNA content analysis was performed to determine the effects of CJ or MJ on cell
cycling in the cancer cell lines. Cells (1x10^) were seeded in 100 mm tissue culture
dishes and treated as described earlier. At termination, cells were harvested, counted,
washed with PBS, fixed in 90% ethanol and stored at 4°C. The cells were then stained
with PI staining solution (lOOpg/ml PI, 0.1% Triton X-IOO, and Img/ml RNase A
(DNase-free) in PBS; 1:1:1 by volume).

Two thousand events were acquired on a

FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA). The percentage of the
cells at different phases o f the cell cycle was obtained using the DNA analysis software
Modfit LT 3.0 (Verity Software House, Topsham, ME).
Fluorescence microscopv
To detect morphological changes characteristic of apoptosis, cells were seeded in
4-well slides and exposed to 0 or 2mM CJ or MJ for 24 hr and 48 hr. At termination,
medium was aspirated off and 500pl of the Hoechst (2pg/ml Hoechst) stain was added to
the cells and incubated for 15 min. Morphological changes (cell blebbing, chromatin
condensation and nuclear fragmentation) indicative of apoptosis were observed and the
images acquired with fluorescence microscopy (Nikon Instruments Inc. Melville, NY).
The number o f cells in the bright field and Hoechst positive cells were counted and the
percentage o f cells undergoing apoptosis was calculated as:
% apoptosis = (Number of Hoechst positive cells / Number of cells in bright field) xlOO.
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DNA gel
DNA was extracted as described in an earlier study [23]. Briefly, cells (IX 10^)
were suspended in lOOpl o f lysis buffer containing 10 mM Tris-HCl (pH 7.4), 10 mM
EDTA, and 0.5% Triton X - 100 for 10 min at 4° C. Cells were centrifuged at 13,000 rpm
for 5 min and RNase A (20pg/ml) was added to the supernatant and incubated for 1 hr at
37° C. Following incubation Proteinase K was added to a concentration of 20pg/ml and
incubated for 30 min at 50° C.

DNA was precipitated with 42mM NaCl and 50%

isoproponal overnight at -20° C. DNA pellet was obtained by centrifugation for 15 min
at 13, 000 rpm. The DNA pellet was resuspended in 20pl TE buffer (lOmM Tris-HCl
and ImM EDTA) and lOpl of the DNA solution was electrophoresed on a 2% agarose
gel in TBE buffer (89 mM Tris base, 89mM boric acid and 2.6 mM EDTA). The Gel
was stained with 1pg/ml ethidium bromide and photographed.
Caspase-3 assav
Caspase-3 activity was measured in PC-3 cells according to the manufacturer’s
instructions. Control and treated cells were harvested, washed, pelleted in microfuge
tubes and stored at -20®C. For protein extraction, 60pl of the extraction buffer containing
DTT (lOpl/lM ) was added for 1x10^ cells and incubated the samples on ice for lOmin.
The cell lysate was clarified at 500xg at 4°C for 5min. Cell lysate was used for the assay,
caspase-3 present in the sample will cleave the fluorescent labeled (AFC) peptide
sequence (DEVD) after aspartate residue. The reaction was monitored by a shift in
fluorescence from blue to green.
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TNFRI expression detection
TNFRI expression was measured by flow cytometry as described by Smolnikar et
al []. DU-145 cells were plated and after two days cells were exposed to 0, ImM, 2mM,
3mM MJ for 24 hr. Following exposure cells were harvested by scraping with PBSEDTA (ImM), counted and Ix 10^ cells were incubated in 50% FBS at 4°C for 15 min.
Cells were washed with PBS-FBS (PBS with 1% FBS added) and incubated with
25pg/ml anti-human TNFRI antibodies (R&D Systems) at 4°C for 60 min. Subsequently
cells were washed three times in PBS-FBS and incubated with FITC- conjugated goat
anti-rat IgG (1:40 dilution) at 4°C for 2 hr. Cells were washed in PBS-FBS three times
and analyzed with FACS Calibur flow cytometer. Fluorescence data was collected and
background fluorescence was determined using unstained cells.

6.4

Statistical analyses

The results were represented as Mean ± SEM of triplicate analyses accompanied
by number o f independent experiments. Statistical analysis was performed using t-test
(Graphpad Software INC., CA, USA and Excel). Differences at p<0.05 or better were
considered statistically signiflcant.

6.5 Results
MJ and CJ inhibited the growth of prostate cancer cells
Both MJ and CJ inhibited the proliferation of prostate cancer cells in a dose and
kinetic dependent manner (Figure 1A, IB, 1C and ID). The concentrations that inhibited
cell proliferation of PC-3 by 50%

(IC 5 0 )

at 24 hr and 48 hr were 2.75mM and 2.37mM for
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MJ (Figure lA), and 3.0mM for CJ at 48 hr (Figure IB). The IC50 values of DU-145 for
MJ are 2 .ImM and 1.8mM at 24 hr and 48 hr (Figure 1C). The CJ IC50 values were
2. ImM and 2.2mM respectively (Figure ID). The effects of exposure to MJ or CJ for 24
hr were also evaluated using a colony formation assay (Figure 2). Both MJ and CJ
inhibited the long-term proliferation of prostate cancer cells in vitro. The IC50 values for
MJ were l.OmM (PC-3), 1.75mM (DU-145) and for CJ are 1.25mM (PC-3) and 1.5mM
(DU-145).

We also investigated the proliferation of cells over 9-day period and we

observed that 2m MJ and 2mM CJ inhibited the 95% of growth of PC-3 and DU-145
cells (Figure 3A and 3B) while control cells continued to grow.
MJ and CJ induced cell cvcle arrest and apoptosis in PC-3 and DU-145 cells
Both CJ and MJ induced cell cycle arrest in prostate cancer cells at 24 hr and 48
hr. CJ and MJ showed S phase arrest in PC-3 cells both at 24 hr and 48 hr (Figure 4). In
DU-145 cells ImM, 2mM and 3mM MJ or CJ caused a prominent block at GO/Gl phase
and 2mM concentration is more effective than the others (Figure 5). We also observed
increased apoptotic population in PC-3 and DU-145 cells with increasing concentration
o f the jasmonates both at 24 hr and 48 hr.
To confirm apoptosis, cells were stained with Hoechst and the images were
acquired with fluorescence microscopy. Percent apoptosis was calculated from Hoechst
positive cells compared to control cells. CJ induced apoptosis in both PC-3 and DU-145
cells. CJ at 24 hr showed 4.79 % apoptosis in PC-3 and 6.67% in DU-145 cells (Figure
6). While MJ treated cells displayed an increase in apoptosis at 48 hr, it was not a
statistically significant increase (Figure 6). DNA fragmentation, a sign of apoptosis was
observed with CJ and MJ (Figure 7). Both of these agents caused a smear at 3 mM
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(Figure 7). All the apoptotic assays confirmed that both CJ and MJ induce apoptosis in
prostate cancer cells.
Jasmonates induced apoptosis involves activation of caspase-3 and expression of TNFRI
CJ and MJ activated caspase-3 in PC-3 and DU-145 cells. Caspase-3 (DEVDase
activity) was activated by 3 hr, which was the earliest time point measured (Figure 8).
Caspase-3 stayed elevated for at least 24 hrs which was the latest time point measured
(Figure 8). In DU-145 cells MJ increased TNFRI expression and is dose dependent. At
all three concentrations of MJ (1, 2, 3) there was an increase in TNFRI activity compared
to the control the highest increase being at 3mM concentration (Figure 9).

6.6

Discussion and conclusion

Jasmonates are novel anticancer agents that have been reported to inhibit the
growth and induce cell death in prostate, melanoma, lung, lymphoma and leukemia cells
[9, 16, 19, 20]. The results presented here as well as previous studies demonstrated that
the jasmonates inhibited the proliferation of hormone independent prostate cancer cells
(PC-3 and DU-145) (Figure 1). Survival assays and proliferation assays showed that both
CJ and MJ inhibit the long-term proliferation (Figures 2 and 3). Cell cycle distribution
demonstrated that CJ and MJ induced S-phase arrest in PC-3 and GO/Gl block in DU-145
cell lines (Figures 4 and 5). Apoptotic studies using flow cytometry and fluorescent
microscopy detected an increased amount of apoptotic cells in treatment groups
compared to control (Figures 4, 5 and 6). DNA fragmentation, an indication of apoptosis,
was also observed in PC-3 cells following MJ exposure (Figure 7). CJ and MJ induced
apoptosis in similar signaling pathways by activating caspase-3 in PC-3 cells (Figure 8).
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To the best o f our knowledge this is the first report to demonstrate that CJ and MJ
inhibited the growth of hormone independent human prostate carcinoma PC-3 and DU145 cells. In prostate cancer cell lines it was found that CJ and MJ inhibited growth is a
result of cell cycle arrest and apoptosis. Cell signaling studies demonstrated that increase
in TNFRI expression and caspase-3 activation result in cell death..
Jasmonates belong to the family of oxygenated fatty acid derivatives, oxylipins,
which are produced via the oxidative metabolism of polyunsaturated fatty acids, usually
linolenic acid (Cigj) [10]. The jasmonates have a variety of effects in both plant and
animal cells. To date, three separate mechanisms have been proposed to explain the
anticancer effects of jasmonates.

These include: (i) the ability of MJ to open the

mitochondrial permeability transition pore complex releasing cytochrome c and inducing
apoptosis [19]; (ii) the ability of MJ to induce the re-differentiation of leukemia cells
[14]; and finally (iii) the ability of MJ to induce the expression of reactive oxygen species
[16]. In addition to inhibiting the proliferation of cancer cell lines while not inhibiting
the growth of normal cell lines, jasmonates can bypass drug resistance induced be either
p53 mutation or by expression of P-gp [10]. In our study we demonstrated that MJ
increases death receptor protein TNFRI expression indicating extrinsic apoptotic
signaling in cancer cells (Figure 9). TNFRI expression was also observed in lung and
breast cancer cells (Manuscripts submitted). These observations clearly indicate that the
jasmonates hold potential as effective phytochemicals in the prevention/treatment of
prostate cancer.
The results presented in this study indicated that jasmonates have the potential to
be chemotherapeutic agents in the treatment of prostate cancer. CJ and MJ induced cell
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cycle arrest and apoptosis in prostate cancer cells, an observation consistent with earlier
reports using other cancer cell lines [9, 16, 19, 20]. Apoptosis is preferred as a targeted
therapy for various cancers including prostate cancer since it does not induce an
inflammatory response [11]. Hormone independent prostate cancer cells typically become
resistant to apoptosis and do not respond to chemotherapeutic agents. This study
demonstrated that both CJ and MJ can induce apoptosis in hormone independent prostate
cancer cells and hence could be useful as chemotherapeutic agents in the management of
advanced prostate cancer [7,18].
The two prostate cancer cell lines studied (PC-3 and DU-145) are deficient in
functional p53 expression and hence are expected to display similar effects on cell cycle
and apoptosis.

However, studies using a variety of phytochemicals indicated that these

two cell lines display differences in responses to these potential anticancer compounds.
In PC-3 cells previous studies reported that resveratrol (a polyphenol found in grapes)
showed GO/Gl arrest at higher concentration (50pM) and transient increase in S-phase at
lower concentrations (10 pM) [4]. Decursin (a coumarin compound) also induced arrest
at GO/Gl, S and G2/M phases depending upon concentration and time in PC-3 and
GO/Gl arrest in DU-145 cells [22]. This study found that in PC-3 cells CJ and MJ caused
S-phase arrest while in DU-145 a GO/Gl arrest was observed. These arrests increased
with both concentration of jasmonate and time of exposure (Figures 4 and 5). Both PC-3
and DU-145 displayed decreased proliferation in the presence of CJ and MJ but the
specific site of cell cycle arrest differed between these two hormone independent prostate
cancer cell lines. The results presented here along with previous studies indicate that
although PC-3 and DU-145 cell lines both lack a functional p53 gene product, their
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responses to phytochemicals are an indication that proteins other than p53 play a crucial
role in the response to these agents.
In conclusion, the results from this study demonstrate anticancer effects of
jasmonates with mechanistic rationale (cell cycle arrest, apoptosis and TNFRI
expression) against advanced (hormone independent) prostate cancer cells. Further
apoptotic pathway studies, in vivo studies and clinical trials will provide the information
necessary to develop jasmonates as novel agents for the prevention and treatment against
prostate cancer.

6.7 Acknowledgments
The authors thank Shirly Shen and Casey Hall for their technical assistance.

This

research was supported in part by ACS grant #IRG-103719 (to JAE) and in part by NIH
Grant Number 2 P20 RR 016464 from the INBRE Program of the National Center for
Research Resources.

6.8 References
1.

Abate-Shen C and Shen MM (2000) Molecular genetics of prostate cancer. Genes

Dev 4; 2410-2434
2.

American Cancer Society, Cancer Facts & Figures (2005) American Cancer

Society, Inc. Atlanta, GA
3.

Aquilina JW, Lipsky JJ, Bostwick DG (1997) Androgen deprivation as a strategy

for prostate cancer chemoprevention. J Natl Cancer Inst 89: 1466-1473.

112

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

4.

Benitez DA, Pozo-Guisada E, Alvarez-Bamentos A, Femandez-Salguero PM,

Castellon EA (2007) Mechanisms involved in resveratrol-induced apoptosis and cell
cycle arrest in prostate cancer-derived cell lines. J Androl 28: 282-293
5.

Chipuk JE, Kuwana T, Boucher-Hayes L, Droin NM, Newmeyer DD, Schuler M,

Green DR (2004) Direct activation of bax by p53 mediates mitochondrial membrane
permeabilization and apoptosis. Science 303: 1010-1014
6.

Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura

Y (1987) The endocrinology and developmental of the prostate. Endocr Rev 8: 338-362.
7.

Deigner HP, Kinscherf R (1996) Modulating apoptosis: current applications and

prospects for future drug development. Curre Med Chem 6: 399-414
8.

Farmer EE, Ryan CA (1990) Interplant communication: Air-borne methyl

jasmonate induces synthesis of proteinases inhibitors in plant leaves. Proc Natl Acad Sci
USA 87: 7713-7716
9.

Fingrut O, Flescher E (2002) Plant stress hormones suppress the proliferation and

induce apoptosis in human cancer cells. Leukemia 16: 608-616
10.

Flescher E (2007) Jasmonates in cancer therapy. Cancer Lett 245: 1-10

11.

Gangduo W, Eddie R, and Quingdi Q (2004) Li. Apoptosis in prostate cancer:

progressive and therapeutic implications. International Journal of Molecular Medicine 14:
23-24
12.

Hamid R, Rotshteyn Y, Rabadi L, Parikh R, Bullock P (2004) Comparison of

alamarBlue and MTT assays for high through-put screening. Toxicol In Vitro 18: 703710
13.

Hengartner MO (2000) The biochemistry of apoptosis. Nature 407: 770-776

113

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

14.

Ishii Y, Kiyota H, Sakai S, Honma Y (2004) Induction o f differentiation of human

myeloid leukemia cells by jasmonates, plant hormones. Leukemia 18: 1413-1419
15.

Johnstone RW, Ruefli AA and Lowe SW (2002) Apoptosis: a link between cancer

genetics and chemotherapy. Cell 108: 153-164
16.

Kim JH, Lee SY, Oh SY, Han SI, Park HG, Yoo MA, Kang HS (2004) Methyl

jasmonate induces apoptosis through induction of Bax/Bcl-XS and activation of caspase3 via ROS production in A549 cells. Oncol Rep 12: 1233-1238
17.

Lei X, Chen Y, Du G, Yu W, Wang X, Qu H, Xia B, He H, Mao J, Zong W, Liao

X, Mehrpour M, Hao X, Chen Q (2006) Gossypol induces Bax/Bak-independent
activation of apoptosis and cytochrome c release via a conformational change in Bcl-2.
FASEBJ 20: 2147-2149
18.

Naik P, Karrim J, Hanahan D (1996) The rise and fall of apoptosis during

multistage tumoregenesis: down-modulation contributes to tumor progression from
angiogenic progenitors. Genes Dev 10: 2105-2116
19.

Rotem R, Heyfets A, Fingrut O, Blickstein D, Shaklai M, Flescher E (2005)

Jasmonates: novel anticancer agents acting directly and selectively on human cancer cell
mitochondria. Cancer Res 65: 1984-1993
20.

Samaila D, Ezekwudo DE, Yimam KK,

Elegbede JA (2004) Bioactive plant

compounds inhibited the proliferation and induced apoptosis in human cancer cell lines,
mvfrro. TIBETS 1:34-42
21.

Thompson CB. (1995) Apoptosis in the pathogenesis and treatment of disease.

Science 267: 1456-1462

114

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

22.

Yim D, Singh RP, Agarwai C, Lee S, Chi H, Agarwal R (2005) A novel

anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate cancer
cells. Cancer Res 65: 1035-1044
23.

Yui S, Saeki T, Kanamoto R, Iwami K (2005) Characteristics of apoptosis in

HCT116 colon cancer cells induced by deoxycholic acid. J Biochem (Tokyo) 138: 151157.

6.9 Figure legends
Figure 1: Cytotoxicity o f CJ and MJ was determined after 24 and 48 hr exposure in
human prostate cancer cells (PC-3 and Du-145). Panel A: PC-3 cells were exposed to MJ
and cell viability was assessed by mitochondrial dehydrogenase assay using alamarBlue
dye as described in methods section. Panel B: PC-3 cells were exposed to CJ. Panel C:
DU-145 cells were exposed to MJ and Panel D: DU-145 cells were treated with CJ. Cell
viability was calculated as a percentage of untreated cells (100%). Values were
Mean±SEM (n=6); results are representative of three independent experiments.

At

1.5mM and higher concentrations of CJ or MJ, there was a significant ($ p<0.0001, one
tailed t-test) decrease in the viability of PC-3 and DU-145 cells compared to the control.
Figure 2: CJ and MJ inhibited the long-term proliferation of PC-3 and DU-145 cells.
Panel A: PC-3 cells were exposed to CJ or MJ for 24 hr. Panel B: DU-145 cells were
exposed to CJ or MJ for 24 hr. The drugs were washed off and the effects on long-term
cell proliferation were determined as explained in methods section. Values are
Mean±SEM; results are representative of two separate experiments of triplicate analyses.
CJ and MJ significantly inhibited the long-term proliferation of PC-3 cells ($ p<0.0001,
one-tailed t-test) at all concentrations studied. At 1.0 mM and higher concentrations of CJ
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significant decrease in survival of DU-145 cells was observed (t p<0.001, one-tailed ttest) whereas MJ showed significant decrease in survival at 1.5 mM and higher
concentrations.
Figure 3: CJ and MJ inhibited the proliferation of prostate cancer cells. Panel A: PC-3
cells were exposed to 2mM CJ or 2mM MJ and number of cells was counted everyday
for 5 days and every alternate day after that until 9 days. Panel B; DU-145 cells were
exposed to 2mM CJ or 2mM MJ and cell number was determined every day for 5 days
and every alternate day after 5 days. Values are Mean+SEM and representative of
triplicate analyses from two different experiments. Both CJ and MJ showed significant
growth inhibition of PC-3 (J p<0.0001) and DU-145 ( | p<0.0001) cells.
Figure 4: CJ and MJ induced cell cycle arrest in PC-3 cells. Cells (1.0x10^) were exposed
to 0 , 1 , 2 and 3mM CJ or MJ for 24 hr (Panels A and C) and 48 hr (Panels B and D). Cell
cycle distribution was determined with FACSCalibur flow cytometry as described in the
materials and methods. Values are Mean+SEM of triplicate analyses.

Data are

representative of two different experiments. Statistical analysis was performed by twotailed t-test and a significant S phase block was observed in PC-3 cells at 24hr (* p<0.05)
(Panel A and C) and 48 hr ( # p<0.01) (Panels B-D). A significant increase in apoptosis
was observed with 3 mM MJ or CJ at both 24 and 48 hrs (Panels A-D).
Figure 5: CJ and MJ induced cell cycle arrest in DU-145 cells. Cells (1.0x10^) were
exposed to 0, 1,2 and 3mM CJ or MJ for 24 hr (Panels A and C) and 48 hr (Panels B and
D). Cell cycle distribution was determined with FACSCalibur flow cytometry as
described in the materials and methods. Values are Mean+SEM of triplicate analyses.
Data are representative o f two different experiments. Statistical analysis was performed
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by two-tailed t-test and significant GO/Gl block was observed at 24 hr ( f p<0.001) and
48 hr (# p<0.01) in DU-145 (Panels A-D).

A significant increase in apoptosis was

observed with 3 mM MJ or CJ at both 24 and 48 hrs (Panels A-D).
Figure 6: CJ and MJ induced apoptosis in PC-3 and DU-145 cell lines. Panel A: PC-3
and DU-145 cells were exposed to 2 mM CJ and 2 mM MJ for 24 hr. Panel B: PC-3 and
DU-145 cells were exposed to 2mM MJ for 48 hr. The percentage of Hoechst positive
cells with morphological changes for apoptosis was calculated as explained in methods.
The results are representative of two separate experiments done in triplicates and values
are represented as Mean+SEM. At 24 hr CJ induced significant increase in apoptosis in
PC-3 (Panel A, * p<0.05, one tailed t-test) and DU-145 (Panel A, # p<0.01, one tailed ttest) cells. At 48 hr 2mM MJ induced apoptosis is not statistically significant (Panel B).
Figure 7: Representative DNA gel picture of PC-3 cells treated with CJ and MJ. (1) DNA
ladder (2) Control cells, (3) ImM CJ, (4) 2mM CJ, (5) 3mM CJ (6) ImM MJ (7) 2mM
MJ (8) 3mM MJ (9) 4 hr sodium deoxycholate (10) 8 hr sodium deoxycholate. Cells
treated with sodium deoxycholate were used as positive controls. DNA smear was
observed with 3mM CJ or MJ and with sodium deoxycholate.
Figure 8: Caspase-3 activity was measured with fiuoremetric kit as explained in methods.
Both CJ (Panel A) and MJ (Panel B) induced activation of caspase-3 from the earliest (3
hr) to the latest time point (24 hr) measured.

At all time points the samples were

incubated with caspase-3 substrate.
Figure 9: Tumomecrosis factor receptor l(TN FRl) activity was measured by flow as
explained in methods. Panel A: DU-145 cells treated with DMSO for 24 hr. Panel B: DU145 cells were exposed to ImM MJ for 24 hr. Panel C: DU-145 cells treated with 2mM
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MJ for 24 hr. Panel D: DU-145 cells treated with 3mM MJ for 24 hr. Cells treated with
MJ showed significant increase in TNFRl expression which was indicated by higher
fluorescence intensity and a shift in histogram peak compared to the control.
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CHAPTER 7

METHYL JASMONATE INDUCES APOPTOSIS VIA TUMOR NECROSIS FACTOR
RECEPTOR 1 IN HUMAN BREAST CANCER CELL LINES
7.1 Abstract
In recent years studies with plant compounds have shown both chemotherapeutic and
chemopreventive properties on cancer cells.

The current study with plant stress

hormones (jasmonates) revealed growth inhibitory effects on breast cancer cells. Both
assays, mitochondrial dehydrogenase and survival demonstrated that CJ and MJ inhibited
the growth o f MDA-MB-435 and MCF-7 cell lines. Cell cycle analysis showed GO/Gl
and S- phase arrest in breast cancer cells. Apoptotic assays demonstrated that jasmonates
induced apoptosis in MDA-MB-435 and MCF-7 cells.

Flow cytometry analysis of

TNFRl expression exhibited activation of TNFRl and cell signaling studies elucidated
that caspase-8, caspase-2, MAPK and caspase-3 were activated. Hence MJ could have
potential applications for chemotherapeutic purposes.

7.2 Introduction
Breast cancer is the second leading cause of cancer deaths among women in the
US [1]. An estimated 40,910 breast cancer deaths and 180, 510 new cases are anticipated
among women in 2007 [1]. Chemotherapy, radiation, surgery and immunotherapy are
among the current treatment options for breast cancer. Chemotherapy using synthetic
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compounds usually shows severe side effects. In recent years studies have shown that
plant compounds have chemotherapeutic and pharmacological activities against wide
type of cancers and could be alternative chemotherapeutic agents with low toxicity [2-7].
Jasmonates are plant stress hormones synthesized in plants in response to injury,
insect attack and wounding [8]. Cis-jasmone (CJ) and methyljasmonate (MJ) belong to
the jasmonte family of compounds. Jasmonates have been reported to inhibit the growth
of leukemia cells, lung and prostate cancer cells [9, 10]. Jasmonates have been shown to
act directly on mitochondria to release cytochrome c for apoptosis induction [11].
Methyl jasmonate induced apoptosis in A549 cells activated bax/bclx/s, and caspase3[12].
Apoptosis is a cellular suicide mechanism that occurs by extrinsic or intrinsic
mechanisms [13].

The extrinsic apoptotic pathway involves a superfamily of death

receptor ligands such as tumor necrosis factor alpha (TNF- a), TNF-related apoptosis
inducing ligand (TRAIL) and FAS (CD95/APO-1) [14]. In breast cancer cells TNFa plays an important role in cellular responses, including inflammation and apoptosis
[15-17].

T N F -a exerts its biological functionality by binding to two membrane

receptors, tumor necrosis factor receptor 1 (TNF-Rl) and tumor necrosis factor receptor 2
(TNF-R2) [16]. The major TNF signaling occurs through TNF-Rl where as TNF-R2 can
only be activated by membrane bound TNF but not by soluble TNF [16]. Activation of
these receptors, recruit FADD (Fas associated death domain) and TRADD (TNF
receptor-associated death domain) leading to activation of caspase-8, mitogen activated
protein kinase (MAPK) and ultimately cell death [16]. Several studies have reported that
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both caspase-8 and MAPK can either directly activate caspase-3 via bid or activate
intrinsic apoptotic pathway [16,18].
MAPK pathway is part of extrinsic apoptotic mechanism, plays important role by
regulating number o f downstream molecules, kinases, scaffold proteins and the balance
between these molecuels exerts cellular responses including cell proliferation, cell cycle
arrest, migration, differentiation and apoptosis.

Takenaka et al. found that the p38-

MAPK pathway was activated during mitotic arrest in mammalian cultured cells [19-27].
Bulavin et al. also reported that p38a-MAPK was activated in response to UV radiation
and induced G2/M cell cycle arrest by decreasing CDC2 activity [22].

CDC2 can

phosphorylate BAD and induce neuronal apoptosis [23]. ERKl and ERK2 kinases have
reported to be activated by phoshorylation in réponse to stress and induced cell death [2427]. MAPK signals intrinsic apoptotic proteins and ultimately causing cell death.
The intrinsic apoptotic pathway can occur either by caspase-8/caspase-2 mediated
bid cleavage or by direct stress to mitochondria. Decrease in mitochondrial membrane
potential leads to cytochrome c release [28-30]. Cytochrome c can form an apoptosome
complex with apaf-1 (apoptotic protease activating factor-1) and procaspase-9.

The

apoptosome complex then activates caspase-3, caspase-6 and caspase-7 resulting cell
death [31].
The effects of CJ and MJ on breast cancer cells were studied using cytotoxicity,
proliferation, DNA content analyses, apoptotic assays, ELISA and western blotting
techniques. This study showed that CJ and MJ inhibited the growth of breast cancer
cells. Cell cycle analysis and apoptotic assays have shown that CJ or MJ induced cell
cycle arrest and apoptosis in breast cancer cell lines.

Studies on membrane fluidity
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demonstrated that MJ decreases membrane fluidity which initiates cell signaling. It was
found that MJ increased TNFRl expression and activated extrinsic apoptotic proteins,
caspase-8, caspase-2 and MAPK. Intrinsic apoptotic mechanism studies demonstrated
that MJ decreased mitochondrial membrane potential and activated caspase-3 in breast
cancer cells. This study indicates that MJ induced apoptosis is associated with a decrease
in membrane fluidity and intracellular signaling via TNFRl, MAPK, caspases-8, caspase2 and caspase-3.

7.3

Materials and methods

Chemicals and reagents
Cell culture media (MEM), fetal bovine serum (FBS) and penicillin (1000 units/ml) and
streptomycin (1000 pg/ml) (P/S) were purchased from GIBCO (Grand Island, NY). Cisjasmone (CJ), methyl j asmonate (MJ), protease inhibitors, propidium iodide (PI),
deoxycholic acid (DCA), 1, 6-biphenyl-1, 2, 6-trihydrazine (DPH) and ribonuclease were
obtained from Sigma Chemical Company (St. Louis, MO). Phosphate buffered saline
(PBS, lacking Ca^^ and Mg^^) was purchased from Invitrogen Corporation (Grand Island,
NY). Sodium dodecylsulfate, bisacrylamide, N, N, N, N^ - tetra-methylethylenediamine
(TEMED) and ammonium persulfate were obtained from Bio-Rad Laboratories
(Hercules, CA). Primary antibody to caspase-3 was obtained from Pharmingen (Franklin
Lakes, NJ) and caspase-8 was from EMD Biosciences (San Diego, CA).

Enzyme

conjugated horse raddish peroxidase (HRP) secondary antibody, standards were obtained
from Santra Cruz Biotechnology, Inc. (Santa Cruz, CA). ECL+ western blotting detection

131

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

system was from Amersham Biosciences (Piscataway, NJ).

All other reagents and

chemicals were of the purest grade and were obtained from reputable vendors.
Cell culture
Breast cancer cell lines (MDA-MB-435, and MCF7) were obtained from ATCC. All
cultures were maintained in MEM supplemented with 10% FBS, 1% of pencillin and
streptomycin (lOOOunits/ml) and HEPES buffer. All the cultures were maintained at
37°C in humidified 5% CO2 atmoshphere. During exposure to the compounds medium
was replaced with treatment medium and control cells received medium with DMSO
(G.1%-0.3%).
Cvtotoxicitv assav
Cells (5000) were plated in 96-well plate and incubated overnight to adhere to the plate.
Cells were exposed to varying concentrations of CJ or MJ for 24hr. At termination
medium was replaced with lOOpl of fresh medium, lOpl of alamarBlue was added and
incubated for 4 hr. After 4 hr fluorescence was measured at 530 nm of excitation and 590
nm of emission wavelengths with Genios fluorescence plate reader (PHENIX Research
Products, Hayward, CA). Cell viability was calculated as percentage of control (100%).
Colonv formation assav
The long-term (delayed) cytotoxic effects of agents on the breast cancer cells were
determined using the colony formation assay (CFA). The cells were exposed to 0.5, 1.0
and 2.0 mM concentrations o f compounds for 24 hr. The treatment medium was poured
off and the cells were washed with IX PBS, harvested with trypsin EDTA, counted and
replated into 60mm dishes. Cells were incubated in humidified CO2 atmosphere at 37°C
for 11 days.

The medium was decanted and cells were stained with crystal violet
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(0.5g/100ml in 95% ethanol).

Colonies (>50 cells/colony) were counted and the

percentage survival (%viability) was calculated relative to the control (100%) group.
Cell cvcle analvsis bv propidium iodide
Cells (0.25x10^) were plated in 100mm tissue culture plates, incubated overnight to
adhere to the plate. Cells were exposed to 0.5mM and 3mM CJ or MJ for 24hr and
washed with IX PBS. Fresh complete medium was added and incubated for 24hr. Cells
were harvested with trypsin EDTA, washed with PBS, counted, fixed with lOOpl o f PBS
and 900pl of absolute ethanol and stored at 4°C prior to DNA content analyses. Samples
were stained with DNA staining solution containing 150pg/ml of PI, 0.1% Triton x-100
and 1mg/ml o f RNase-A (DNase fi*ee) (1:1:1 by volume) and incubated in dark for an
hour. Acquisition of the data was carried out with FACSCalibur flow cytometer (Becton
Dickinson, Sanjose, CA) and analyzed with ModfitLT 3.0 software (Verity Software
House, Topsham, ME).
Detection of apoptosis bv Hoechst and DNA fragmentation
Cells (0.01x10^) were plated in 4-well slides and incubated for 24hr before
treatment. Cells were exposed to 3.0mM CJ or MJ for 24hr, at termination medium was
aspirated off, stained with Hoechst (2pg/ml Hoechst) for 15min. Morphological changes
indicative of apoptosis were observed and the images acquired with fluorescence
microscopy (Nikon Instruments Inc. Melville, NY). The number of cells in the bright
field and Hoechst stained cells were counted and percentage of apoptotic cells was
calculated as:
% apoptosis = (Number of Hoechst positive cells/Number of cells in bright field) x 100
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Cells (1x10^) were seeded in 75mm tissue culture flask and treated with 1, 2 and
3mM MJ for 24 hr. Cells treated with DCA for 4hr and 8hr were positive controls. At
termination cells were harvested with trypsin EDTA, washed with IX PBS and DNA was
extracted as described in an earlier study [38]. Briefly, cells (IX 10®) were suspended in
lOOpl of lysis buffer containing 10 mM Tris-HCl (pH 7.4), 10 mM EDTA, and 0.5%
Triton X- 100 for 10 min at 4° C. Cells were centrifuged at 13,000 rpm for 5 min and
RNase A (20pg/ml) was added to the supernatant and incubated for 1 hr at 37° C.
Following incubation Proteinase K was added to a concentration of 20pg/ml and
incubated for 30 min at 50° C.

DNA was precipitated with 42mM NaCl and 50%

isoproponal overnight at -20° C. DNA pellet was obtained by centrifugation for 15 min
at 13, 000 rpm. The DNA pellet was resuspended in 20pl TE buffer (lOmM Tris-HCl
and ImM EDTA) and lOpl of the DNA solution was electrophoresed on a 2% agarose
gel in TBE buffer (89 mM Tris base, 89mM boric acid and 2.6 mM EDTA). The Gel
was stained with 1pg/ml ethidium bromide and photographed.
Membrane fluiditv studies
Cells (0.5 X 10®) were plated in 75mm tissue culture flask and incubated for two days.
Cells were exposed to 3mM MJ, lOuM cholesterol, 500uM DCA for 4 hr. At termination
cells were harvested, washed with PBS, fluorescence dye DPH (2pM) was added and
polarization was measured with LS 55 Luminescence Spectrometer (Perkin Elmer) P
value was calculated by using the following formula:
I w - IGF X Ivhl GF = Ihv/Ihh
P = I w + (GF X Ivh)
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TNFRl expression detection
TNFRl expression was measured by flow cytometry as described by Smolnikar et
al. MDA-MB-435 and MCF-7 cells were plated and after two days cells were exposed to
0, ImM, 2mM, 3mM MJ for 24 hr. Following exposure cells were harvested with PBSEDTA (ImM), counted and 1x10® cells were washed in 50% FBS at 4°C for 15 min.
Cells were washed with PBS-FBS (PBS with 1% FBS added) and incubated with
25pg/ml anti-human TNFRl antibodies (R&D Systems) at 4“C for 60 min. Subsequently
cells were washed three times in PBS-FBS and incubated with FITC- conjugated goat
anti-rat IgG (1:40 dilution) at at 4°C for 2 hr. Cells were washed in PBS-FBS three times
and analyzed with FACS Calibur flow cytometer. Fluorescence data was collected and
background fluorescence was determined using unstained cells.
MAPK assav bv ELISA
p38 and ERKl/2 activity was determined by an ELISA assay kit (Super array,
Frederick MD). Cells (1.5 X 10'*) were plated in a 96-well plate and incubated overnight
in humidified 5% CO2 atmosphere at 37°C. The following day, cells were serum starved
for 18-24 hr, exposed to MJ and assayed. Briefly, adherent cells were fixed to the plate,
washed, blocked and incubated with a primary antibody followed by a secondary
antibody. Then developing solution was added and the samples were allowed to incubate
for 10 min at room temp, before the stop solution was added. Absorbance was measured
at 450 nm.

Relative phosphorylation was normalized to cell number according to

manufacturer’s instructions.

135

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Metabolism of MJ in arachidonic acid pathways
Cells (0.5 X 10"*) were plated in 96-well plate and incubated overnight. Cells
were exposed to lipoxygenase, cycloxygenase and p450 inhibitors and IC50 MJ for 24 hr.
At termination medium was aspirated off, fresh medium, alamarBlue was added and
incubated for 4hr. Fluorescence measurements were taken with Genios

plate reader

(PHENIX Research Products, Hayward, CA). Cell viability was calculated as percentage
of control ( 100%).
Caspase-8. 2. 3 and membrane potential studies
The expression o f caspase-3, and caspase-8 was determined using western blot
analysis. Control or treated (1.0x10®) cells were harvested with trypsin EDTA, pelleted
into microfuge tubes at 1000 rpm for 10 min, stored in -80°C and protein extraction was
carried out according to the manfacturer’s instructions (Biosource Intl. Inc., Camarillo,
CA). The cell pellet was thawed on ice for 2hr prior to protein extraction. lOOpl of
extraction buffer containing protienase inhibitor (250pl/5ml) and PMSF (ImM) was
added to 1x10® cells, with occasional mixing for every 10 min about 30 min. The cell
lysate was centrifuged at 13,000 rpm at 4°C for 10 min; supernatant was collected,
aliquoted into tubes and stored at -80°C. Total protein concentration was determined
using BCA protein assay kit (Pierce, Rockford, IE). Equal amount of protein was loaded,
subjected to SDS-PAGE and transferred to PVDF membrane.

The membrane was

blocked for 1 hr at room temperature with blocking solution ( 10% nonfat dry milk
solution + 0.05% tween 20%) and washed twice with IX western wash (12.4 mM trizma,
37.4 mM NaCl, 0.5% TritonX-100, pH 7.4),. Then blot was incubated with primary
antibodies (Ipg/ml) to caspase-3 or caspase-8 for Ihr at room temperature. Followed by
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washing three times with IX western wash primary antibody was detected with 1:1000
diluted horse raddish peroxidase (HRP) or fluorescence secondary antibodies.

HRP

antibody signal was developed with ECL+ detection kit (Amersham Biosciences,
Piscataway, NJ) and visualized with TYPHOON 9410 (Amersham Biosciences,
Piscataway, NJ).
Caspase-3 and caspse-2 activity was measured by flow cytometry as described in
manufacturers protocol (Biovision, CA). Briefly cells were exposed to 3mM MJ for 4
and 24 hr, harvested, counted and washed with PBS. Caspase-3 and caspase-2 substrates
were added and washed with wash buffer (provided by the manufacturer) and activity
was measured by flow cytometry.
Mitochondrial membrane potential was measured as described in manufacturer’s
protocol (Cell technology, CA).
incubated overnight.

MDA-MB-435 and MCF-7 cells were plated and

Cells were exposed to 0, IC50MJ (concentration that inhibits

growth of 50% of cells), 3mM MJ for 24 hr.

At termination cells were harvested,

counted, washed with PBS, 0.5 X 10® cells were stained with JC-1 reagent and incubated
for 15 min at 37° C.

Cells were washed twice with assay buffer (provided by

manufacturer) and membrane potential was measured by flow cytometry.

Intact

mitochondria will have red color fluorescence and the dye appears green in the cytosol.

7.4

Statistical analyses

The results were presented as Mean ± SEM of replicate analyses accompanied by number
of independent experiments. Statistical analyses were performed using one or two tailed
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t-test (Graphpad Software Inc., San Diego CA and Microsoft Excel).

Differences at

p<0.05 or better were considered statistically significant.

7.5 Results
CJ and MJ inhibited the growth of breast cancer cells
Proliferation inhibition of breast cancer cells was determined by cytotoxicity
assay using almarBlue dye. Plant compounds CJ and MJ inhibited the growth of breast
cancer cell lines in-vitro. The concentration of CJ at which 50% of MDA-MB-435 cells
growth (IC50) was inhibited after 24 hr treatment was 1.7 mM, 2.5 mM for MCF-7 cells
(Figure lA). The IC50 of MJ for MDA-MB-435 was 1.9 mM and 2.0 mM for MCF-7
cells (Figure IB). CJ and MJ were not cytotoxic to CDC-1070-SK and MCF-lOA normal
cells (Figure 1C)
Inhibition o f long-term proliferation of breast cancer cells by CJ or MJ was
evaluated by clonogenic survival assay. The concentration of CJ at which 50% o f long
term proliferation of MDA-MB-435 and MCF-7 cells was inhibited (IC50) after 24 hr
treatment was 1.2mM (Figure 2A). The IC50 of MJ for MDA-MB-435 was 1.2mM and
1.45mM for MCF-7 respectively (Figure 2B). A time course with MDA-MB-435 and
MCF-7 cells at 3mM CJ or MJ showed time dependent decrease in survival (Figure 2C
and 2D). At 2 hr, CJ inhibited the long-term proliferation of 70% of M DA-MB-435,60%
of MCF-7 cells while MJ inhibited the long-term proliferation of 70% of both MDA-MB435 and MCF-7 cells in-vitro (Figure 2C and 2D).
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Cell cvcle analvsis
To investigate the cell cycle arrest DNA content analyses was carried out by
propidium iodide staining using flow cytometry. Representative histograms of MDAMB-435 and MCF-7 cells treated with CJ and MJ showed an increase in apoptotic peak
compared to the control (Figure 3A and 3B). CJ and MJ induced cell cycle arrest and
apoptosis in breast cancer cell lines (Figure 3). CJ and MJ induced GO/Gl arrest in
MDA-MB-435 and in MCF-7 cell lines (Figure 3C and 3D). At 3mM MJ MDA-MB-435
cells showed a block at S-phase while 3mM CJ showed an S-phase block in MCF-7 cells
(Figure 3C and 3D). An increase in sub-diploid population was observed with 3mM MJ
in both MDA-MB-435 and MCF-7 cells (Figure 3C and 3D).
Apoptotic assav
Apoptotic studies have demonstrated that CJ or MJ induced apoptosis in breast
cancer cells (Figure 3). To confirm apoptosis induction cells were stained with Floechst,
images were acquired with fluorescence microscopy and percent of apoptotic cells were
calculated as explained in methods (Table 1).

Cells treated with CJ or MJ showed

morphological changes o f apoptosis (cell shape had changed to elongated from oval) and
increased significant amount of apoptosis in breast cancer cells (Figure 4 A, 4B, 4C and
4D). MDA-MB-435 and MCF-7 cells showed 35.0% and 37.2% apoptosis with MJ. CJ
induced 6.6% (MDA-MB-435) and 43.5% (MCF-7) apoptosis respectively (Table 1).
Further studies on DNA laddering with MJ after 24 hr treatment showed DNA
smear in MDA-MB-435 cells but not in MCF-7 cells (Figure 4F). DNA smear was
observed only with 3mM MJ but not with! or 2mM MJ (Figure 4F). DNA laddering was
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observed in MDA-MB-435 cells treated with DCA for 4 and 8 hr which were positive
controls (Figure 4F).
Membrane fluiditv
MJ is a hydrophobic molecule and expected to decrease the membrane fluidity of
cells. Cells treated with cholesterol and DCA were positive controls. MDA-MB-435 and
MCF-7 cells treated with 3mM MJ, DCA and cholesterol for 4hr showed an increase in P
value compared to the control (Table 2). An increase in P value indicates a decrease in
the membrane fluidity in both the cell lines (Table 2).
Cellular signaling
Studies on death receptor elucidated that TNFRl expression was increased and
initiated death signals in breast cancer cells.

TNFRl increased expression was dose

dependent in both MD-MB-435 and MCF-7 cells (Figure 5A-5H).

To confirm cell

signaling caspase-8, caspase-2 and MAPK activity was measured. Increased p38 and
ERKl/2 activity was observed after exposure of cells to MJ. p38 was activated starting at
2.0hr and ERKl/2 activity was observed after l.Ohr treatment with 3mM MJ in MDAMB-435 but not in MCF-7 cell line (Figure 5H and 51, MCF-7 data not shown). Caspase8 was activated starting at 2hr in MDA-MB-435 cells treated with 3mM MJ but not in
MCF-7 cells (Figure 6A). Procaspase-8 was cleaved and activated until 8 hr in MDAMB-435 cells (Figure 6A). In MCF-7 cells caspase-2 was activated at 4 hr (Figure 6B,
6C and 6D-westem will be carried out to confirm). To elucidate the involvement of
mitochondria in response to MJ induced apoptosis mitochondrial membrane potential and
i

caspase-3 activity was measured. MJ treated cells showed decreased membrane potential
and procaspase-3 activity compared to the control except in caspase-3 mutant cell line
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MCF-7 (Figure 6E, 6F and 6G). Flow cytometry analysis demonstrated that caspase-3
activity was increased in MDA-MB-435 cell line without any change in MCF-7 cells
(Figure 6F).
MJ metabolism through arachidonic acid pathways
MJ resembles arachidonic acid in its structure and hence MJ is expected to
metabolize through arachidonate pathways.

MDA-MB-435 cells were treated

simultaneous with lipoxygenase, cycloxygenase and p450 inhibitors and IC50MJ
(survival). If MJ metabolizes through these pathways, inhibitor treatment would increase
the viability of cells. There was no increase in viability of cells treated simultaneously
with inhibitors and MJ. MJ does not metabolize through arachidonate pathways (data not
shown).

7.6

Discussion and conclusion

Breast cancer is the second leading cause of cancer related deaths among women
in the US.

Alternative strategies are required to combat the breast cancer deaths.

Jasmonates are plant compounds, which have shown growth inhibitory and apoptotic
activities on lung and prostate cancer cells. How ever the chemotherapeutic effects of
these compounds have not been investigated in breast cancer cells.
Results presented here demonstrated that jasmonates inhibit growth, induce cell
cycle arrest and apoptosis in breast cancer cells. Studies on signaling mechanisms with
MJ showed activation o f TNFRl, caspase-8, p38, ERKl/2, and caspase-3 as well as
mitochondrial membrane potential decrease in MDA-MB-435 cells.

In MCF-7 cell

signaling studies showed TNFRl expression, caspase-2 activation and decrease in
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mitochondrial membrane potential.

This study indicates that MJ activates different

signaling mechanisms depending on cell line. This is the first report to demonstrate that
MJ decreases membrane fluidity and activated the death receptor TN FR l.
Recent reports with MJ showed growth inhibition of lung and leukemia cells [9].
Along similar lines, this study demonstrated that jasmonates inhibited the growth of
breast cancer cells. It was reported that MJ induced apoptosis in human lung cancer cell
line, A549 and this study determined that CJ and MJ induced apoptosis in MDA-MB-435
and MCF-7 cell line. Cell cycle analysis revealed that CJ and MJ induced a block at
GO/Gl in MDA-MB-435 and MCF-7 cells at all concentrations that were studied except
in MCF-7 cells at 0.5 mM MJ or CJ an S-phase block was observed. This result indicates
that the observed cell death was due to cell cycle arrest and apoptosis.
Earlier studies reported that the hydrophobic molecule DCA changes membrane
fluidity. DCA decreases membrane fluidity by rearranging cholesterol in the membrane
which makes the membrane tighter [35].

It has been reported that DCA induced

apoptosis involves activation of caspases-2, caspase-3, caspase-7 and caspasea-8 in colon
cancer cells (HT-29) [36-38]. In HCT-116 colon cancer cells DCA activated p38 and
ERKl/2. Using pharmacological inhibitors to ERKl/2 determined that elevated ERKl/2
activity suppressed DCA induced apoptosis. Taken together it suggests that DCA can
activate different apoptotic proteins based on cell line [36-38].

No mechanism was

proposed, however, activation of these molecules likely results due to the activation of
receptor molecule (i e TNFRl) due to changes in membrane fluidity in the presence of
DCA. Since MJ is a hydrophobic molecule like DCA it might work in a similar manner
i.e.

decreases

membrane

fluidity

which

assembles

receptors

and
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leads

to

autophosphorylation and activation of death receptors. This study determined that MJ
decreased membrane fluidity results in apoptotic signaling in cancer cells. The results
presented here (TNFRl, caspase-2, caspase-8, capase-3 and MAPK) and by others
indicated that jasmonates induced apoptosis involves activation of multiple signaling
pathways [9, 11, 2].
In conclusion, plant compounds have decreased membrane fluidity which further
activated TNFRl. This study is important because apoptotic pathway can be manipulated
for therapeutic purposes. MJ has shown to act on three different types of cancer cells
hence it could be used for wide variety of cancer treatments. To reduce the toxicity of
conventional chemotherapy to patients’ and improve the efficacy future combination
studies (i.e MJ and cisplatin) at low dosage need to be carried out.
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7.9 Figure legend
Figure 1: Cytotoxicity of CJ or MJ on human breast cancer cells (MDA-MB-435 and
MCF-7) as well as on human normal cells (CDC-1070-SK and MCF-lOA) in culture.
Panel A: MDA-MB-435 and MCF-7 cells were exposed to varying concentrations of CJ
for 24 hr. Panel B: MDA-MB-435 and MCF-7 cells were exposed to MJ for 24 hr. Panel
C: CDC-1070-SK and MCF-lOA were exposed to different concentrations of MJ for 24
hr. The effects on cell viability were determined by mitochondrial dehydrogenase assay
using alamarBlue dye as described in methods section. Cell viability was calculated as a
percentage o f untreated cells (100%). Values were Mean±SD (n=6); results are
representative of three independent experiments. At concentrations 1.5mM and higher
there was a significant decrease in the viability of breast cancer cells compared to the
control. One tailed t-test was carried out and at concentration 1 mM and above we
observed statistically significant (p < 0.0001) decrease in viability. MJ was not cytotoxic
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to CDC-1070-SK and MCF-lOA cells (Panel C). Results are representative of three
different experiments.
Figure 2: CJ and MJ inhibited the long-term proliferation of breast cancer cells. Panel
A: MDA-MB-435 cells were exposed to varying concentrations of CJ or MJ for 24hr.
Panel B: MCF-7 cells were exposed to varying concentrations CJ or MJ for 24 hr. Panel
C: MDA-MB-435 cells were exposed to 3mM CJ or MJ for 0, 2, 4 and 8 hr. Panel D:
MCF-7 cells were exposed to 3mM CJ or MJ for 0, 2, 4 and 8 hr. At termination the
drugs were washed off and the effects on long term cell proliferation were determined.
Colonies (>50 cells/colony) were counted and survival was calculated as percentage of
control cells (100%). Values are Mean+SEM; results are representative o f duplicate
analyses o f two separate experiments. CJ and MJ significantly inhibited the long-term
proliferation o f all two cell lines in dose and time dependent manner (p<0.001; one tailed
t-test). Results are representative of two independent experiments.
Figure 3: Panel A: Representative histograms of MDA-MB-435 cells treated with 3mM
CJ or MJ for 24 hr. Panel B: Representative histograms of MCF-7 cells treated with 3mM
CJ or MJ. Panel C: MDA-MB-435 cells were treated with 0.5mM and 3mM CJ or MJ for
24 hr. Both CJ and MJ induced a significant GO/Gl block in MDA-MB-435 cells and
3mM MJ also induces S-block with increasing sub-diploid population. Panel D; CJ and
MJ induced GO/Gl block in MCF-7 cells and 3mM CJ also induced S-block while 3mM
MJ increased

sub-diploid population.

(Two-tailed t-test, p<0.05).

Results

are

representative o f two different experiments.
Figure 4: To confirm apoptosis induction in breast cancer cells were stained cells with
Hoechst and fluorescence microscopy images were acquired. Panel A: Bright field image

149

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

o f MDA-MB-435 control cells (treated with 0.03% DMSO) Panel B: Hoechst image of
MDA-MB-435 control cells. Panel C: Bright field image o f MDA-MB-435 cells treated
with 3mM CJ for 24hr. Morphological changes of apoptosis (cell shape changed from
spherical to elongated and nuclear condensation was observed). Panel D: Hoechst image
of MDA-MB-435 cells treated with 3mM CJ. Hoechst positive cells were observed.
Hoechst positive cells with morphological changes were considered as apoptotic cells.
Percent apoptosis was calculated as explained in the methods. Results are representative
of two different experiments. Panel F: DNA gel picture of MDA-MB-435 and MCF-7
cells treated with MJ for 24 hr. Lane 1; High DNA Mass™ Ladder shows 1000, 2000,
3000, 4000, 6000, 10000 bp bands. Lane 2: MDA-MB-435 cells treated with 0.03%
DMSO (Control). Lane 3: MDA-MB-435 cells treated with ImM MJ. Lane 4: MDAMB-435 cells treated with 2mM MJ. Lane 5: MDA-MB-435 cells treated with 3mM MJ.
Lane 6: MDA-MB-435 cells were treated with DCA for 4hr. Lane 7: MDA-MB-435 cells
were treated with DCA for 8 hr. Lane 8: MCF-7 cells treated with 0.03% DMSO
(Control). Lane 9: MCF-7 cells treated with ImM MJ. Lane 10: MCF-7 cells treated with
2mM MJ. Lane 11 : MCF-7 cells treated with 3mM MJ. DNA smear was observed only in
MDA-MB-435 cells treated with 3mM MJ and DCA treated cells were used as positive
controls. Results are representative of three different experiments.
Figure 5: Increase in TNFRl and MAPK activity was measured as explained in methods.
Panel A: TNFRl expression in MDA-MB-435 control. Panel B: TNFRl expression in
MDA-MB-435 cells treated with ImM MJ for 24 hr. Panel C: TNFRl expression in
MDA-MB-435 cells treated with 2mM MJ. Panel D: TNFRl expression in MDA-MB435 cells treated with 3mM MJ. Increase in TNFRl expression is dose dependent and at
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3mM MJ a complete shift in fluorescence intensity was observed. Panel E; TNFRl cells
treated with 0.3% DMSO. Panel F: TNFRl expression in MCF-7 cells treated with ImM
MJ. Panel G: TNFRl expression in MCF-7 cells treated with 2mM MJ. Panel H:
TNFRl expression in MCF-7 cells treated with 3mM MJ.

In MCF-7 cells TNFRl

expression is dose dependent and huge increase at 3mM MJ was observed. Panel I: In
MDA-MB-435 cells increase in p38 phosphorylation was significant at 2hr (p<0.04) and
starts decreasing from 4 hr till 8 hr. Panel J: In MDA-MB-435 cells significant increase
in ERKl/2 phosphorylation was observed at Ihr (p<0.04). Results are representation of
two independent experiments.
Figure 6: Panel A: Western blot of caspase-8 in MDA-MB-435 cells treated with 3mM
MJ for 2 hr, 4 hr and 8 hr. Procaspase-8 was processed and cleaved to active caspase-8 at
all the time points studied. Caspase-8 activity was increased with 3mM MJ treatment in
MDA-MB-435 cells compared to the control. P-actin was a loading control. Panel B, C
and D; Histograms of caspase-2 in MCF-7 cells. Panel B; MCF-7 cells treated with 0.3%
DMSO Panel C: MCF-7 cells were treated with 3mM MJ for 4hr. A shift in fluorescence
intensity was observed compared to control. Panel D: MCF-7 cells were treated
simultaneously with 3mM MJ for 4 hr and caspase-2 inhibitor. Shift in fluorescence
intensity was decreased compared to 3mM MJ treatment.

Panel E: Western blot of

procaspase-3. Decreased levels of procaspase-3 were observed in MDA-MB-435 cells
treated with 3mM MJ.

Panel F: Caspase-3 activity measurement by flow cytometry

showed activation o f caspase-3 in MDA-MB-435 cells but not in MCF-7 cells. Fold
increase was calculated with respect to the control (1). Results are representative of two
different experiments. Panel G: Mitochondrial membrane potential was determined in
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breast cancer cells as explained in methods. In both MDA-MB-435 and MCF-7 cells
IC50 MJ and 3mM MJ decreased the membrane potential as observed by an increase in
green fluorescence compared to the control.

152

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Table 1: CJ and MJ induced apoptosis in breast cancer cells.

Cell lines
MDA-MB-435
MCF-7

0

% apoptosis
3.0mM CJ
3.0mM MJ

2.2±0.87
2.0±2.0

6.6+0.94
43.5+3.53

35.0+8.72
37.2±5.64

MDA-MB-435 and MCF-7 cells were exposed to 3mM CJ or MJ for 24 hr, stained with
Hoechst and % apoptosis was calculated as explained in methods. Both CJ and MJ
induced significant amount o f apoptosis (p<0.01)
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Table 2: MJ decreases membrane fluidity in Breast cancer cells.

Treatment (4hr)

MB-435

MCF-7

Control

0.29 ±0.05

0.32±0.005

Cholesterol

0.50 ±0.05

0.41±0.01

DCA

0.44 ±0.04

0.4±0.0

3mM MJ

0.40 ±0.05

0.41±0.01

MDA-MB-435 cells were treated with 3mM MJ for 4hr and polarization was measured
and P value was calculated as explained in methods. There is significant decrease in
membrane fluidity. (p<0.05, one tailed t-test)
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CHAPTER 8

PERILLYL ALCOHOL AND METHYL JASMONATE SENSITIZE BREAST
CANCER CELLS TO CISPLATIN VIA TNFRl
8.1 Abstract
Introduction-The aim of the study was to evaluate the activity of a combination of perillyl
alcohol (POH), methyl jasmonate (MJ) with cisplatin to define the most effective
schedule, and to investigate the mechanism of action in human breast cancer cells.
Methods-The study was performed on MDA-MB-435 cells. The cytotoxic activity was
evaluated by mitochondrial dehydrogenase assay. Cell cycle analysis and an apoptotic
assay were performed by flow cytometry. TNFRl activity and mitochondrial membrane
potential were measured by flow cytometry.
Results- The POH, MJ treatment enhanced the cytotoxicity for subsequent exposure to
cisplatin. Combination treatment of POH and MJ blocked cells at the GO/Gl phase of the
cell cycle and the addition o f cisplatin forced the cells to progress through the cell cycle
or killed them. POH and MJ treatment activated TNFRl and it was further activated by
the addition o f cisplatin. Mticohondrial membrane potential was decreased with POH
and MJ treatment which was further enhanced by cisplatin treatment.
Conclusion-This study revealed that POH, MJ and cisplatin together were more effective
than single drug or two drugs in combination. It was also demonstrated that combination
treatment activated TNFRl and decreased mitochondrial membrane potential.
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8.2 Introduction
Breast cancer, patients have several treatment options including surgery,
chemotherapy, radiation therapy and a combination of these therapies.

Due to

disadvantages with single agent chemotherapy drug combinations at tolerable doses are
administered to increase efficacy [1]. New strategies for breast cancer treatment such as
the use o f plant compounds in combination with chemotherapeutic drugs will improve the
efficacy o f current therapeutic regimens.
Perillyl alcohol (POH) and Methyl jasmonate (MJ) are plant compounds that can
be used for combination therapy. POH is a naturally occurring monoterpne that inhibited
growth of cancer cells and induced apoptosis [2-5]. A recent study reported that POH
sensitized human myeloid U937 cells to pentoxifylline. Combination treatment of POH
with pentoxyfylline increased Bclz and Bax expression as well as induced apoptosis [6].
POH has been reported to sensitize prostate and malignant glioma cells to
cisplatin/radiation via Fas mediated death receptor pathway [7, 8]. Malignant glioma
cells preincubation with POH demonstrated a dose dependent sensitivity to cisplatin and
doxorubicin [8]. MJ is a plant stress hormone that inhibited growth of lung, breast and
leukemia cells [9-11].

Combination studies of MJ with cisplatin, adriamycin, taxol,

l,3bis {2-chloroethyl}-1 -nitusourea (BCNU) showed super-additive effects with BCNU
and cisplatin in human pancreas carcinoma MIA PaCa-2 cells [11]. MJ in combination
with taxol showed cooperative effects in MCF-7 cells but not in combination with
cisplatin [11]. MJ enhances ATP depletion in the presence of glycolysis inhibitor, 2DG
in CT26 (murine colon carcinoma) and D122 (murine lung carcinoma) cells [11]. These
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observations with combinations of plant compounds and chemotherapeutic drugs will
provide new avenues for breast cancer treatment.
Cisplatin has antitumorigenic activities against wide variety of cancers but its
nephrotoxicity limits the amount given to patients.

Several groups have shown that

cisplatin caused nephrotoxicity is a result of TNF-a release [12-14]. T N F -ais
a proinflamatory cytokine, involved in diseases such as arthritis and multiple sclerosis.
Its binds to two receptors, tumor necrosis factor receptor 1 (TNFRl) and tumor necrosis
factor 2 (TNFR2) [15-19]. In B6 PTC (proximal tubular cells) cells (from C57BL/6 (B6)
mice) cisplatin treatment increases TNF-a production and Fas expression [I2].TNF-a
release in cell culture medium and Fas activation led to cell death in mice proximal
tubular cells [12]. Hence, agents that sensitize cells to low dose of cisplatin will result in
fewer side effects for the patient.
This study demonstrated that POH inhibited the growth of human breast cancer
cells (MDA-MB-231, MDA-MB-435 and MCF-7) and induced apoptosis. The novel
finding in the study is that POH (IC20), MJ (IC20) and of cisplatin (IpM ) in combination
showed synergistic effects in growth inhibition in MDA-MB-435 cells. The IC50 for
cisplatin is 600 pM and in combination with POH and MJ it decreases to 1 pM which is a
600 fold in increase in sensitivity to cisplatin.

It was observed that combination

treatment activated TNFRl and decreased mitochondrial membrane potential in MDAMB-435 cells.
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8.3 Materials and methods
Chemicals and reagents
Cell culture media (MEM), fetal bovine serum (PBS) and penicillin (1000
units/ml) and streptomycin (1000 pg/ml) (P/S) were purchased from GIBCO (Grand
Island, NY). Cis-jasmone (CJ), methyl jasmonate (MJ), cisplatin, propidium iodide (PI)
and ribonuclease were obtained from Sigma Chemical Company (St. Louis, MO).
Phosphate buffered saline (PBS, lacking Ca^^ and Mg^^) was purchased from Invitrogen
Corporation (Grand Island, NY). All other reagents and chemicals were o f the purest
grade and were obtained from reputable vendors.
Cell culture
Breast cancer cell lines (MDA-MB-231, MDA-MB-435, and MCF7) were
obtained from ATCC (Manassas, VA).

All cultures were maintained in MEM

supplemented with 10% FBS, 1% of pencillin and streptomycin (lOOOunits/ml) and
HEPES buffer.

All the cultures were maintained at 37°C in humidified 5% CO2

atmosphere. During exposure to the compounds medium was replaced with treatment
medium containing various agents while control cells received medium with DMSO
(0.1%-0.3%).
Cvtotoxicitv assav
Cells (5000) were plated in a 96-well plate and incubated overnight to adhere to
the plate. Cells were exposed to varying concentrations of cisplatin and POH for 24hr.
For combination treatments cells were exposed to either two or three compounds for 24
hr. The concentration o f POH or MJ was always at a dose that resulted in 20% decrease
in cell viability (IC20) by the individual compound. Two agent combinations included:
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cisplatin and POH, cisplatin and MJ as well as POH and MJ, while the three agent
combination included POH, MJ and cisplatin. At termination the medium was replaced
with lOOpl o f fresh medium, lOpl of alamarBlue was added and incubated for 4 hr. After
4 hr fluorescence was measured at 530 nm excitation and 590 nm emission wavelengths
with Genios fluorescence plate reader (PHENIX Research Products, Hayward, CA). Cell
viability was calculated as percentage of control (100%).
Colonv formation assav
The long-term (delayed) cytotoxic effects of agents on the breast cancer cells
were determined using the colony formation assay (CFA). The cells were exposed to 0.5,
1.0 and 2.0 mM concentrations of agents for 24 hr. The treatment medium was poured off
and the cells were washed with IX PBS, harvested with trypsin EDTA, counted and
replated into 60mm dishes. Cells were incubated in humidified CO2 atmosphere at 37°C
for 11 days.

The medium was decanted and cells were stained with crystal violet

(0.5g/100ml in 95% ethanol).

Colonies (>50 cells/colony) were counted and the

percentage survival was calculated relative to the control (100%) group.
Cell cvcle analvsis bv propidium iodide
Cells (0.5x10^) were plated in 100mm tissue culture plates, incubated overnight to
adhere to the plate. Cells were exposed to 2mM POH for 24hr and washed with IX PBS.
Fresh complete medium was added and incubated for 24hr. For combination treatments
cells were exposed to either two or three compounds for 24 hr. The concentration of
POH or MJ was always at a dose that resulted in 20% decrease in cell viability (IC20) by
the individual compound.

Two agent combinations included: cisplatin and POH,

cisplatin and MJ as well as POH and MJ, while the three agent combination included
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POH, MJ and cisplatin. Cells were harvested with trypsin EDTA, washed with PBS,
counted, fixed with lOOpl o f PBS and 900pl of absolute ethanol and stored at 4°C prior to
DNA content analyses. Samples were stained with DNA staining solution containing
150pg/ml of PI, 0.1% Triton x-100 and 1mg/ml of RNase-A (DNase free) (1:1:1 by
volume) and incubated in the dark for an hour. Acquisition of the data was carried out
with a FACSCalibur flow cytometer (Becton Dickinson, Sanjose, CA) and analyzed with
ModfitLT 3.0 software (Verity Software House, Topsham, ME).
Detection of apoptosis bv Hoechst
Cells (1x10"^) were plated in 4-well slides and incubated for 24hr before treatment.
Cells were exposed to 2mM POH for 24hr, at termination medium was aspirated off and
stained with Hoechst (2pg/ml Hoechst) for 15min. Morphological changes indicative of
apoptosis were observed and the images were acquired with fluorescence microscopy
(Nikon Instruments Inc. Melville, NY).

The number of cells in the bright field and

Hoechst stained cells were counted and percentage of apoptotic cells was calculated as:
% apoptosis = (Number of Hoechst positive cells/Number of cells in bright field) x 100.
TNFRl expression detection
TNFRl expression was measured by flow cytometry [20]. MDA-MB-435 and
MCF-7 cells were plated and after two days cells were exposed to 0, ImM, 2mM, 3mM
MJ for 24 hr.

Following exposure cells were harvested by scraping in PBS-EDTA

(ImM), counted and 1x10^ cells were incubated in 50% FBS at 4°C for 15 min. Cells
were washed with PBS-FBS (PBS with 1% FBS added) and incubated with 25pg/ml anti
human TNFRl antibodies (R&D Systems, Emeryville, CA) at 4°C for 60 min.
Subsequently cells were washed three times in PBS-FBS and incubated with FITC-
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conjugated goat anti-rat IgG (1:40 dilution) at 4°C for 2 hr. Cells were washed in PBSFBS three times and analyzed with FACS Calibur flow cytometer. Fluorescence data
was collected and background fluorescence was determined using unstained cells.
Mitochondrial membrane potential studies
Mitochondrial membrane potential was measured as described in manufacturer’s
protocol (Cell technology, Mountain View, CA). MDA-MB-435 cells were plated and
incubated overnight. Cells were exposed to different combinations of cisplatin, POH and
MJ (IC20 POH and MJ or IC20 POH (concentration that kills 20% of cells) and cisplatin
(IpM ) or IC20 MJ and cisplatin as well as combination of IC20POH, IC20MJ and
cisplatin) for 24 hr. At termination cells were harvested, counted, washed with PBS, 0.5
X 10^ cells were stained with JC-1 reagent and incubated for 15 min at 37° C. Cells were
washed twice with assay buffer (provided by manufacturer) and membrane potential was
measured by flow cytometry. Intact mitochondria have a red color fluorescence which
changes to green with a decrease in mitochondrial membrane potential.

8.4

Statistical analyses

The results were presented as Mean ± SEM of replicate analyses accompanied by the
number of independent experiments. Statistical analyses were performed using one or
two tailed t-test (Graphpad Software Inc., San Diego CA and Microsoft Excel).
Differences at p<0.05 or better were considered statistically significant.
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8.5 Results
POH inhibited the proliferation of breast cancer cells
The proliferation inhibition of breast cancer cells was determined by cytotoxicity
assay using almarBlue dye. POH inhibited breast cancer cell growth in vitro. MDA-MB231 and MDA-MB-435 were the most sensitive to POH (Figure lA). The IC20 value
was calculated by visual inspection. The concentration of POH at which 20% of MDAMB-231 cells growth (IC20) was inhibited after 24 hr treatment was 1.0 mM, 0.6 mM for
MDA-MB-435 and 0.8 mM for MCF-7 cells (Figure lA).

Long-term proliferation

inhibition o f breast cancer cells by POH was evaluated by clonogenic survival assay
(Figure IB).

The concentration of POH at which 50% of MDA-MB-231 cells

proliferation was inhibited after 24 hr treatment was 1.5 mM, 1.5 mM for MDA-MB-435
and 0.8 for MCF-7 cells (Figure IB). At ImM POH MCF-7 cells showed 25% survival
whereas MDA-MB-231 and MDA-MB-435 cells showed 95% survival. POH at 2mM
resulted in 2% survival in all three cell lines (Figure IB). Cell cycle analyses showed a
GO/Gl block in all three breast lines studied (Figure 2).
Combination studies demonstrated that POH, MJ and cisplatin showed cytotoxic
effects in growth inhibition compared to POH and MJ, POH and cisplatin as well as MJ
and cisplatin treatments (Figure 3A). POH and MJ together showed only 25% growth
inhibition in MDA-MB-435 cells (appendix).
Cell cvcle arrest and apoptosis in breast cancer cells
To investigate the cell cycle arrest, DNA content analyses was carried out by
propidium iodide staining using flow cytometry. POH produced a block in the cell cycle
and also induced apoptosis in breast cancer cell lines (Figure 2). POH induced GO/Gl

167

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

arrest with increasing the sub diploid population (apoptotic population) in MDA-MB-231
(Figure 2A and 2B), MDA-MB-435 (Figure 2C and 2D) and MCF-7 (Figure 2E and 2F)
cells. Studies with combination treatments showed a GO/Gl block at all combinations
that were studied with increasing sub-diploid population (Figure 3B)
POH induced apoptosis in breast cancer cells (Table 1).

To further confirm

apoptosis induction cells were stained with Hoechst, images were acquired with
fluorescence microscopy and percent of apoptotic cells was calculated as explained in
methods. POH showed significant increase in apoptosis with breast cancer cell lines
(Table 1). POH induced 33.7% apoptosis in MDA-MB-231, 12.1% in MDA-MB-435
and 12.6% in MCF-7 respectively (Table 1)
TNFRl activation
TNFRl activation was measured by flow cytometry.

TNFRl activation was

observed in combination treatments in MDA-MB-435 cells.

A shift in fluorescence

intensity o f histograms was observed in POH and MJ, POH and cisplatin, MJ and
cisplatin as well as in POH, MJ and cisplatin treatments.

The largest increase in

fluorescence intensity was observed with the combination treatment of POH, MJ and
cisplatin. The results indicated that three drugs (POH, MJ and cisplatin) in combination
activated larger amounts o f TNFRl in MDA-MB-435 cells compared to drugs in
combination of two (POH and MJ, POH and cisplatin as well as MJ and cisplatin).
Mitochondrial membrane potential detection:
To determine the involvement of mitochondria in combination treatment of POH,
MJ and cisplatin membrane potential of mitochondria was measured by flow cytometry.
It was demonstrated that mitochondrial membrane potential was decreased in
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combination treatments compared to the control. The highest decrease in membrane
potential was observed with a combination treatment of POH, MJ and cisplatin.

8.6 Discussion and conclusion
Combination therapies will provide an alternate treatment option to reduce the
toxicity and increase the efficacy of single agent therapy.

This is the first report to

demonstrate that POH, MJ and cisplatin in combination resulted in growth inhibition.
DNA content analysis with combination treatments showed a GO/Gl block with
increasing hypo-diploid population (apoptosis). Studies on the mitochondrial membrane
potential and TNFRl indicated decreased mitochondrial membrane potential and
activation of TNFRl in POH and MJ, POH and cisplatin, MJ and cisplatin as well as
POH, MJ and cisplatin treatments.
Previous studies reported that POH inhibited the growth of lung, prostate and
colon cancer cells [2-5]. It has been reported that POH induced GO/Gl block in lung and
colon cancer cells as well as G2/M block in prostate cancer cells with increasing the
apoptotic population [9-11].

Along similar lines this study demonstrated that POH

inhibited growth, induced a GO/Gl block and caused apoptosis in breast cancer cells.
Previous studies on MJ showed cytotoxic effects at 1-5 mM range in lung and leukemia
cells [9-11]. Cisplatin at 6.6pM inhibited 48% cell growth and combination with 50lOOpM silibinin resulted in 63-80% growth inhibition of prostate cancer cells [21]. In
this study it was demonstrated that cisplatin at IpM concentration showed 2 % growth
inhibition whereas with IC20POH and IC20 MJ showed 68 % growth inhibition. The
IC50 (50% growth inhibition) value of cisplatin in MDA-MB-435 cells was 0.6 mM and
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cisplatin in combination with IC20POH and IC20MJ decreased the IC50 to 1 pM which
is a 600 fold shift in IC50. This indicated that treatment of breast cancer cells with plant
compounds increased cisplatin cellular toxicity.
Earlier reports on combination studies with POH and cisplatin demonstrated that
POH sensitized prostate cancer cells to cisplatin and activated the Fas mediated death
pathway and decrease mitochondrial membrane potential [7, 22]. Cisplatin was reported
to release TNF-a into the cell culture medium and activated TNFRl in proximal tubular
cells [13, 14]. In our previous studies it was determined that MJ activated TNFRl in
prostate and breast cancer cells and decreased membrane potential in breast cancer cells
(manuscripts submitted).

Taken together all these observations and the combination

studies demonstrated that POH, MJ and cisplatin treatment activated TNFRl and
decreased mitochondrial membrane potential.

The proposed mechanism for growth

inhibition with combination treatment includes TNF-a release by cisplatin exposure and
activation o f TNFRl as well as mitochondrial membrane potential decrease by MJ and
POH.
Cancer patients have disadvantages with single agent therapy such as side effects
and severe toxicity. Combination studies involving two or more agents to reduce toxicity
and improve efficacy of chemotherapy will provide new avenues for cancer treatment.
This study indicated that combination treatments activated TNFRl and further scheduling
and mechanistic studies at different doses need to be carried out to improve the efficacy
of cisplatin.
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8.9 Figure legend
Figure 1: Cytotoxicity o f POH on human breast cancer cells MDA-MB-231, MDA-MB435 and MCF-7. Panel A: MDA-MB-231, MDA-MB-435 and MCF-7 cells were exposed
to varying concentrations of POH for 24 hr and viability was measured by mitochondrial
dehydrogenase assay as explained in the methods section. Cell viability was calculated
as a percentage of untreated cells (100%). Values were Mean±SEM (n=6); results are
representative of three independent experiments. A one tailed t-test was carried out and
at concentrations of 1 mM and above a statistically significant (p < 0.0001) decrease in
viability was observed. Panel B: POH inhibited the long-term proliferation of breast
cancer cells. Cells were exposed to varying concentrations of POH and percent survival
was determined as explained in the methods section. MDA-MB-231 and MDA-MB-435
cells showed significant decrease in survival at 2mM POH (p<0.001) whereas in MCF-7
cells both 1 and 2 mM POH caused significant decrease in survival (one tailed t-test,
p<0.001). Values were Mean±SEM (n=3); results are representative of two independent
experiments.
Figure 2: Representative histograms of breast cancer cell lines exposed to 2mM POH.
Panel A: MDA-MB231 cells were exposed to 0.2% DMSO for 24 hr to compensate for
the DMSO present in cisplatin treated cells. Panel B: MDA-MB-231 cells were exposed
to 2 mM POH for 24 hr. Panel C: MDA-MB-435 cells were exposed to 0.2% DMSO for
0, 24 hr. Panel D: MDA-MB-435 cells were exposed to 2 mM POH for 24 hr. Panel E:
MCF-7 cells were exposed to 0.2% DMSO for 24 hr Panel F: MCF-7 cells were exposed
to 2 mM POH for 24 hr. POH induced significant GO/Gl (two tailed t-test, p<0.01) arrest
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in all three cell lines studied

Values are MeantSEM; results are representative of

duplicate analyses o f two separate experiments
Figure 3: Panel A: Cells were exposed to cisplatin alone, cisplatin with IC20 POH,
cisplatin with IC20 MJ and cisplatin with IC20POH and IC20MJ. Combination of POH,
MJ and cisplatin enhanced growth inhibition compared to the drugs in combination of
two. Panel B: Cells were exposed to POH, MJ and cisplatin as explained in methods
section. A significant GO/Gl block was observed at all combinations that were studied
with increasing the sub-diploid populations. (Two tailed t-test, p<0.05)
Figure 4: In MDA-MB-435 cells activation of TNFRl was measured by flow cytometry.
Panel A; Cells were exposed to 0.2% DMSO to compensate for the DMSO present in
cisplatin treated cells. Panel B: Cells were exposed to 1C20 POH for 24 hr. Panel C:
Cells were exposed to 1C20 MJ for 24 hr. Panel D: Cells were exposed to cisplatin
(IpM ) for 24 hr. Panel E: Cells were exposed to 1C20 POH and 1C20 MJ for 24 hr.
Panel F: Cells were exposed to 1C20 POH and cisplatin (IpM ). Panel G: Cells were
exposed to IC20 MJ and cisplatin (IpM ). Panel H. Cells were exposed to IC20 POH,
IC20 MJ and cisplatin (IpM ) for 24 hr.

TNFRl activation was observed only in

combination treatments (POH and MJ, POH and cisplatin, MJ and cisplatin as well as in
POH, MJ and cisplatin treated cells) which was determined by a shift in fluorescence
intensity o f histograms. Results are representative of two independent experiments.
Figure 5: Mitochondrial membrane potential was determined in breast cancer cells using
a fluorescent dye. Panel A: MDA-MB-435 cells were exposed to DMSO. Panel B: Cells
were exposed to IC20 POH for 24 hr. Panel C: Cells were exposed to IC20 MJ for 24 hr.
Panel D: Cells were exposed to IC20POH and IC20 MJ for 24 hr. Panel E: Cells were
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exposed to IpM cisplatin for 24 hr. Panel F: Cells were exposed to IC20 POH and IpM
cisplatin for 24 hr. Panel G: Cells were exposed to IC20 MJ and 1pM cisplatin. Panel H;
Cells were exposed to IC20POH, IC20 MJ and IpM cisplatin. In MDA-MB-435
treatments an increase in green fluorescence indicated decreased membrane potential.
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Table 1: POH induced apoptosis in breast cancer cells

Cell lines
MDA-MB-231
MDA-MB-435
MCF-7

Control

2.0mM POH

9.84±0.16
2.2±0.87
2.0+2.0

33.7±5.71
12.1+2.14
12.6+2.33

POH showed significant increase in apoptotic population compared to the control in all
three breast cancer cells (one tailed t-test; p<0.01).
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CHAPTER 9

SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS
9.1 Novel findings
1. Jasmonates inhibited the growth of prostate and breast cancer cells.
2. Jasmonates induced cell cycle arrest and apoptosis in prostate and breast cancer
cells.
3. Jasmonates decreased the membrane fluidity of breast cancer cells and activated
the death receptor pathway.
4. MJ activated TNFRl in lung, prostate and breast cancer cells.
5. MJ activated caspase-8, caspase-2 (western needs to be done to confirm), MAPK,
caspase-3 and also decreased the mitochondrial membrane potential of breast
cancer cells
6. Combination studies enhanced growth inhibition of breast cancer cells with POH,
MJ and cisplatin. Results demonstrated activation of TNFRl with combination
treatment of POH, MJ and cisplatin at low doses.
7. MJ sensitized breast cancer cells to radiation.
8. Microarray analysis on breast cancer cells with MJ showed changes in gene
expression prolife. Further studies need to be carried out to confirm the specific
changes (i.e.: CDC25, ASF-1) in gene expression.
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9.2 Jasmonates
Earlier,

Flescher et al.,

demonstrated that jasmonates possess cytotoxic

and

antitumorigenic properties and also reported that jasmonates inhibited the growth of
leukemia cells [7]. Along similar lines, this study revealed that jasmonates inhibit the
growth o f lung, prostate and breast cancer cells which are the three most commom forms
of cancer (Chapters 3-8).

Mitochondrial dehydrogenase assay demonstrated that the

breast cancer cell line, MDA-MB-435 is more sensitive to CJ or MJ than other cell lines
that were tested. To understand the rationale behind the growth inhibition, cell cycle
analysis was performed and the process of cell death (apoptosis or necrosis) was
investigated. It was found that jasmonates induce cell cycle arrest and apoptosis in all
three different types of cancer cell lines that were studied, which is in agreement with the
literature [7, 8]. DNA content analyses showed that jasmonates induced a G2/M block in
lung cancer cells, a Gq/Gi arrest in prostate cancer cells and Gq/Gi and S-phase arrest in
breast cancer cells. This is the first report to demonstrate that CJ and MJ increase p21
levels in cancer cells, which confirms the cell cycle arrest caused by these compounds.
Previous studies have demonstrated that jasmonates induce apoptosis by selectively
causing damage to mitochondria [8]. On the other hand, the current study shows that MJ
affects the membrane fluidity of cancer cells and sends death signals via TN FRl. It has
been determined that jasmonates decrease membrane fluidity and causes receptors to
converge and become activated.

It has been reported that a hydrophobic molecule,

deoxycholic acid (DCA) decreases membrane fluidity and activates downstream proteins
such as MAPK [65-67].

Since jasmonates are hydrophobic molecules they probably

work in a manner similar to DCA.

Another novel finding in the study is tiiat, MJ
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activated TNFRl in all three different types of cancer cells. To further confirm TNFRl
expression, caspase-8 and caspase-2 (initiator caspases) activation was measured and
found to be activated. A finding that is consistent with the activation of TNFRl. Further
studies on intrinsic apoptotic mechanisms showed that MJ decreased mitochondrial
membrane potential and activated caspase-3 resulting in cell death which is in agreement
with the literature [8,42].

9.3 Monoterpenes
Earlier reports showed that growth of lung, prostate and colon cancer cells was inhibited
by PA and POH [29-32]. In this study, PA and POH inhibited growth, induced cell cycle
arrest and apoptosis in lung and breast cancer cells. A novel finding of this study is that
PA increased p21, Bela levels, activated bax and caspase-3 resulting in apoptosis.

9.4

Combination treatments

Several groups have demonstrated that combination therapy could be a new approach for
cancer treatment. Combination studies with PA and POH showed that lung cancer cells
were sensitized to

cisplatin and radiation following pretreatment with these

monoterpenes. To the best o f our knowledge, this is the first report to demonstrate that
MJ sensitized cells to radiation. An interesting observation is that MJ (IC50MJ 2hr) at
sensitized breast cancer cells to low dose radiation (2 Gy) (Appendix). This could have
clinical benefit because MJ being a plant compound would be less toxic to cells than
other chemotherapeutic drugs (i.e. cisplatin) and low dose radiation does not have any
severe side effects. Combination of POH and MJ with cisplatin at very low dose showed

185

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

synergistic effects in growth inhibition while molecular mechanism studies measured a
decrease in the mitochondrial membrane potential and increased TNFRl activation in
breast cancer cells. Hence combination studies with low dosage of drugs could result in
significant clinical improvement for patients on single agent therapies

9.5

Significance of novel findings

The novel findings of this study are significant for several reasons. The results of this
study are consistent with the literature reports about plant compounds effects on leukemia
cells [7, 8]. The results have been expanded to lung, prostate and breast cancer cells
which are three most common forms of solid tumors. Compounds studies (POH and MJ
with cisplatin as well as MJ and radiation) indicate that these plant compounds will
improve the efficacy of conventional treatments.

Activation of multiple signaling

pathways by MJ and broad activity on different types of cancer cells (lung, prostate and
breast) suggests that MJ will be effective on wide variety of cancers. Results presented in
this preclinical study provide useful information for future animal and clinical studies.
This study supports the literature about plant compounds effects on cancer cells and
also expands research on lung, prostate and breast cancer cells. Plant compounds usually
are less toxic to the cells which makes this research important.

Plant compounds

inducing cell cycle arrest will help control the growth of cancer cells and ultimately lead
to cell death.

Results presented in this study with cancer cell lines provide useful

information for future animal and clinical studies. Combination studies (POH and MJ
with cisplatin, MJ and radiation) will improve the efficacy of conventional treatments.
Activation o f multiple signaling pathways by MJ and broad activity on different types of
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cancer cells (lung, prostate and breast) suggests that MJ can be effective on wide variety
of cancers.

9.6 Future Directions
•

Does MJ cause the release of TNF-a like cisplatin and thereby result in an

autocrine response and activation o f TNFRl?
•

Structure and function study of jasmonates: Will CJ (member of jasmonate family)

affect the cancer cells in similar manner to MJ? Will others in jasmonate family (24
different compounds) work through the same mechanism as MJ did in inducing
apoptosis?
•

MJ can be modified chemically which hopefully will increase cellular toxicity: Will

phenyl group addition make MJ more hydrophobic and more effective on cancer cells?
Will addition of more hydroxyl groups make MJ hydrophilic and decrease the potential
cytotoxic effects of MJ?
•

Will MJ activate any other death receptors FAS, DR1-DR6?

•

Does combination treatment of POH, MJ and cisplatin involve any other signaling

pathways like MAPK and FAS?
•

What is the mechanism involved in MJ induced sensitivity to low dose radiation?

•

Animal studies: Preventive studies will involve MJ by itself, MJ derivatives and MJ

in combination with other drugs such as POH as well as cisplatin. This will provide
information about the toxicity o f MJ, derivatives of MJ and MJ in combination with other
drugs.

187

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

APPENDIX
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Figure 1: DC4, DB46, MDA-MB-435 and MCF-7 cells were exposed to CJ or MJ for 24
hr and viability was measured as explained in methods. At concentrations 1.5 mM and
higher CJ and MJ showed significant decrease in viability (p<0.001).
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Figure 2: MCF-7, T47-D, SK-BR-3 and ZR-751 cells were exposed to CJ and MJ for 24
hr. Cell viability was measured as explained in methods. At concentration 1.5 mM and
above both CJ and MJ inhibited the growth o f breast cancer cells (p<0.001).

189

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

A

■IR

120 1

IC50MJ+IR

100

8060 ■
4020-

0

1

2

3

4

5

6

Gy

B
120 1
IR
100

IC50MJ+IR

80-

4020-

0

1

2

3

4

5

6

Gy
Figure 3: MDA-MB-435 (A) and MCF-7 (B) cells were exposed to IR alone and a
combination o f MJ (2hr) and IR (2Gy). Survival assay was carried out as explained in
the methods. MJ sensitized breast cancer cells to radiation (p<0.01).
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Figure 4: A549 cells were exposed to 0.3% DMSO (A) and 3mM MJ (B) for 24 hr and
TNFRl activation was determined by flow cytometry.

In A549 cells TNFRl was

activated which was observed by the shift in fluorescence intensity.
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Figure 5: Cells were exposed to IC20 POH, IC20MJ as well as IC20 POH and IC20 MJ
for 24 hr and viability was measured as by alamarBlue assay.

POH and MJ in

combination decreased 30% viability in MDA-MB-435 cells.
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ABBREVIATIONS
CDK

Cyclin dependent kinases

CJ

Cis-jasmone

DMSO

Dimethyl sulfoxide

EDTA

Ethylene diammine tetraacetic acid

FACS

Fluorescence activated cell sorting

FBS

Fetal bovine serum

FITC

Fluorescence isothiocyanate

IR

Ionizing radiation

MAPK

Mitogen activated protein kinases

MJ

Methyl j asmonate

NSCLC

Non small cell limg cancer cells

PA

Perillic acid

PBS

Phosphate buffer saline

POH

Perillyl alcohol

SDS-PAGE

Sodium dodecyl sulfate-polyacrylamide gel electrophoresis

TNF-a

Tumor necrosis factor alpha

TNFRl

Tumor necrosis factor -1

TNFR2

Tumor necrosis factor -2
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